,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,357,2,1,,11111288,5202,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
1,357,2,1,,11111289,5202,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
2,410,1,5,,11111288,5202,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
3,410,1,5,,11111289,5202,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
4,411,2,1,,11111288,5202,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
5,411,2,1,,11111289,5202,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
6,444,1,1,,11111288,5202,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
7,444,1,1,,11111289,5202,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
8,445,3,1,,11111288,5202,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
9,445,3,1,,11111289,5202,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
10,446,1,1,,11111288,5202,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
11,446,1,1,,11111289,5202,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
12,447,1,1,,11111288,5202,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
13,447,1,1,,11111289,5202,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
14,448,1,2,,11111288,5202,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
15,448,1,2,,11111289,5202,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
16,450,1,2,,11111288,5202,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
17,450,1,2,,11111289,5202,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
18,451,1,2,,11111288,5202,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
19,451,1,2,,11111289,5202,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
20,526,1,1,,11111288,5202,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
21,526,1,1,,11111289,5202,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
22,530,1,1,,11111288,5202,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
23,530,1,1,,11111289,5202,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
24,584,1,3,,11111288,5202,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
25,584,1,3,,11111289,5202,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
26,585,1,4,,11111288,5202,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
27,585,1,4,,11111289,5202,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
28,587,1,5,,11111288,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
29,587,1,5,,11111289,5202,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
30,588,1,4,,11111288,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
31,588,1,4,,11111289,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
32,589,1,3,,11111288,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
33,589,1,3,,11111289,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
34,590,1,3,,11111288,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
35,590,1,3,,11111289,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
36,591,1,4,,11111288,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
37,591,1,4,,11111289,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
38,592,1,6,,11111288,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
39,592,1,6,,11111289,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
40,593,1,4,,11111288,5202,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
41,593,1,4,,11111289,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
42,594,1,4,,11111288,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
43,594,1,4,,11111289,5202,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
44,595,1,3,,11111288,5202,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
45,595,1,3,,11111289,5202,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
46,596,1,2,,11111288,5202,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
47,596,1,2,,11111289,5202,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
48,597,1,3,,11111288,5202,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
49,597,1,3,,11111289,5202,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
50,603,1,2,,11111288,5202,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
51,603,1,2,,11111289,5202,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
52,605,1,2,,11111288,5202,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
53,605,1,2,,11111289,5202,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
54,607,1,3,,11111288,5202,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
55,607,1,3,,11111289,5202,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
56,662,1,1,,11111288,5202,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
57,662,1,1,,11111289,5202,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
58,875,1,2,,11111288,5202,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
59,875,1,2,,11111289,5202,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
60,875,1,2,,26754231,5202,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
61,879,1,2,,11111288,5202,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
62,879,1,2,,11111288,5202,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
63,880,2,1,,11111289,5202,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
64,880,2,1,,11111289,5202,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
65,880,2,1,,26754231,5202,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
66,880,2,1,,26754231,5202,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
67,880,2,1,,26754232,5202,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
68,880,2,1,,26754232,5202,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
69,880,2,1,,26754233,5202,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
70,880,2,1,,26754233,5202,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
71,881,2,2,,11111288,5202,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
72,881,2,2,,11111289,5202,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
73,881,2,2,,26754231,5202,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
74,883,1,3,,11111288,5202,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
75,883,1,3,,11111289,5202,Inconclusive,13699818.0,1559.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
76,884,1,2,,11111288,5202,Inconclusive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
77,884,1,2,,11111289,5202,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
78,884,1,2,,26754231,5202,Inconclusive,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
79,885,1,2,,11111288,5202,Inactive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
80,885,1,2,,11111289,5202,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
81,885,1,2,,26754231,5202,Inactive,13435386.0,1576.0,39.8107,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
82,886,1,2,,11111288,5202,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
83,886,1,2,,11111288,5202,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
84,886,1,2,,11111289,5202,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
85,886,1,2,,11111289,5202,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
86,887,1,2,,11111288,5202,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
87,887,1,2,,11111289,5202,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
88,887,1,2,,26754231,5202,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
89,889,1,3,,11111288,5202,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
90,889,1,3,,11111289,5202,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
91,889,1,3,,26754231,5202,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
92,891,1,2,,11111288,5202,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
93,891,1,2,,11111289,5202,Inconclusive,40805836.0,1565.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
94,892,1,2,,11111288,5202,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
95,892,1,2,,11111289,5202,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
96,892,1,2,,26754231,5202,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
97,893,1,2,,11111288,5202,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
98,893,1,2,,11111288,5202,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
99,893,1,2,,11111289,5202,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
100,893,1,2,,11111289,5202,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
101,893,1,2,,26754231,5202,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
102,893,1,2,,26754231,5202,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
103,894,2,1,,11111289,5202,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
104,894,2,1,,26754231,5202,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
105,895,1,2,,11111288,5202,Inactive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
106,899,1,2,,11111288,5202,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
107,899,1,2,,11111289,5202,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
108,900,1,3,,11111288,5202,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
109,900,1,3,,11111289,5202,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
110,900,1,3,,26754231,5202,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
111,901,1,2,,11111288,5202,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
112,901,1,2,,11111289,5202,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
113,901,1,2,,26754231,5202,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
114,902,1,2,,11111288,5202,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
115,902,1,2,,11111289,5202,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
116,902,1,2,,26754231,5202,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
117,912,1,2,,11111288,5202,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
118,912,1,2,,11111289,5202,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
119,914,1,3,,11111288,5202,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
120,914,1,3,,11111289,5202,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
121,915,1,3,,11111288,5202,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
122,915,1,3,,11111289,5202,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
123,917,1,3,,11111288,5202,Inactive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
124,918,1,3,,11111288,5202,Inconclusive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
125,923,1,2,,11111288,5202,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
126,923,1,2,,11111289,5202,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
127,923,1,2,,26754231,5202,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
128,924,1,2,,11111288,5202,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
129,924,1,2,,11111289,5202,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
130,924,1,2,,26754231,5202,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
131,925,1,2,,11111288,5202,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
132,925,1,2,,11111289,5202,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
133,926,1,2,,11111288,5202,Inconclusive,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
134,926,1,2,,11111289,5202,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
135,927,1,3,,11111288,5202,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
136,927,1,3,,11111289,5202,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
137,928,1,2,,11111288,5202,Inactive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
138,938,1,2,,11111288,5202,Active,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
139,938,1,2,,11111289,5202,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
140,943,1,2,,11111288,5202,Inconclusive,18249941.0,25229.0,0.1,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
141,944,1,2,,11111288,5202,Inconclusive,18249941.0,25229.0,22.3872,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
142,945,1,4,,11111288,5202,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
143,954,1,2,,11111288,5202,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
144,957,1,2,,11111288,5202,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
145,958,1,2,,11111288,5202,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
146,959,1,4,,11111288,5202,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
147,992,1,3,,11111288,5202,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
148,995,1,2,,11111288,5202,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
149,995,1,2,,11111289,5202,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
150,995,1,2,,26754231,5202,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
151,997,1,2,,11111288,5202,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
152,998,1,2,,11111288,5202,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
153,1030,2,1,,11111289,5202,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
154,1030,2,1,,26754231,5202,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
155,1030,2,1,,26754232,5202,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
156,1030,2,1,,26754233,5202,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
157,1332,1,1,,49698514,5202,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
158,1379,1,2,,11111289,5202,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
159,1379,1,2,,26754231,5202,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
160,1452,1,1,,11111288,5202,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
161,1452,1,1,,11111289,5202,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
162,1452,1,1,,26754231,5202,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
163,1454,1,1,,11111289,5202,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
164,1454,1,1,,26754231,5202,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
165,1457,1,1,,11111289,5202,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
166,1457,1,1,,26754231,5202,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
167,1457,1,1,,26754232,5202,Inactive,44888968.0,83523.0,19.9526,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
168,1457,1,1,,26754233,5202,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
169,1458,1,1,,11111289,5202,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
170,1458,1,1,,26754232,5202,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
171,1458,1,1,,26754233,5202,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
172,1460,1,3,,26754231,5202,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
173,1460,1,3,,26754232,5202,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
174,1460,1,3,,26754233,5202,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
175,1463,1,1,,26754231,5202,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
176,1463,1,1,,26754232,5202,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
177,1463,1,1,,26754233,5202,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
178,1467,1,3,,11111289,5202,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
179,1467,1,3,,26754231,5202,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
180,1468,1,1,,26754231,5202,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
181,1468,1,1,,26754232,5202,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
182,1468,1,1,,26754233,5202,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
183,1469,1,1,,11111289,5202,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
184,1469,1,1,,26754231,5202,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
185,1469,1,1,,26754232,5202,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
186,1469,1,1,,26754233,5202,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
187,1471,2,1,,11111288,5202,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
188,1471,2,1,,11111289,5202,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
189,1471,2,1,,26754231,5202,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
190,1471,2,1,,26754232,5202,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
191,1471,2,1,,26754233,5202,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
192,1476,2,1,,11111289,5202,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
193,1476,2,1,,26754231,5202,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
194,1477,1,1,,11111289,5202,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
195,1477,1,1,,26754231,5202,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
196,1477,1,1,,26754232,5202,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
197,1477,1,1,,26754233,5202,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
198,1478,2,1,,11111289,5202,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
199,1478,2,1,,26754231,5202,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
200,1479,1,2,,11111289,5202,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
201,1479,1,2,,26754231,5202,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
202,1479,1,2,,26754232,5202,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
203,1479,1,2,,26754233,5202,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
204,1487,1,1,,11111289,5202,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
205,1490,2,1,,11111289,5202,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
206,1490,2,1,,26754231,5202,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
207,1490,2,1,,26754232,5202,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
208,1490,2,1,,26754233,5202,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
209,1519,1,3,,11111289,5202,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
210,1519,1,3,,26754231,5202,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
211,1766,1,1,,11111289,5202,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
212,1766,1,1,,11111289,5202,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
213,1766,1,1,,26754231,5202,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
214,1766,1,1,,26754231,5202,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
215,1768,1,1,,11111289,5202,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
216,1768,1,1,,11111289,5202,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
217,1768,1,1,,26754231,5202,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
218,1768,1,1,,26754231,5202,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
219,1851,1,2,,11111288,5202,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
220,1851,1,2,,11111289,5202,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
221,1851,1,2,1.0,11111288,5202,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
222,1851,1,2,1.0,11111289,5202,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
223,1851,1,2,2.0,11111288,5202,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
224,1851,1,2,2.0,11111289,5202,Inconclusive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
225,1851,1,2,3.0,11111288,5202,Inconclusive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
226,1851,1,2,3.0,11111289,5202,Inactive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
227,1851,1,2,4.0,11111288,5202,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
228,1851,1,2,4.0,11111289,5202,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
229,1851,1,2,5.0,11111288,5202,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
230,1851,1,2,5.0,11111289,5202,Inconclusive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
231,1865,1,1,,11111289,5202,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
232,1865,1,1,,26754231,5202,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
233,1865,1,1,,26754232,5202,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
234,1865,1,1,,26754233,5202,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
235,1948,1,1,,11111289,5202,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
236,1948,1,1,,26754231,5202,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
237,2062,1,2,,85208925,5202,Active,,,,,Ligands of bioamine (Class A) GPCRs,Other,,
238,2101,1,1,,11111289,5202,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
239,2101,1,1,,26754231,5202,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
240,2101,1,1,,26754232,5202,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
241,2101,1,1,,26754233,5202,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
242,2107,1,1,,11111289,5202,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
243,2107,1,1,,26754231,5202,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
244,2107,1,1,,26754232,5202,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
245,2107,1,1,,26754233,5202,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
246,2112,1,1,,11111289,5202,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
247,2112,1,1,,26754231,5202,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
248,2112,1,1,,26754232,5202,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
249,2112,1,1,,26754233,5202,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
250,2147,1,1,,11111289,5202,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
251,2147,1,1,,26754231,5202,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
252,2451,1,2,,11111289,5202,Inconclusive,122920737.0,,15.8114,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
253,2451,1,2,,26754231,5202,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
254,2472,1,2,,11111289,5202,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
255,2472,1,2,,26754231,5202,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
256,2517,2,1,,11111289,5202,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
257,2517,2,1,,26754231,5202,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
258,2517,2,1,,26754232,5202,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
259,2517,2,1,,26754233,5202,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
260,2528,1,2,,11111289,5202,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
261,2528,1,2,,26754231,5202,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
262,2546,1,1,,11111289,5202,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
263,2546,1,1,,26754231,5202,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
264,2549,1,1,,11111289,5202,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
265,2549,1,1,,26754231,5202,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
266,2549,1,1,,26754232,5202,Inconclusive,282403581.0,,39.8107,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
267,2549,1,1,,26754233,5202,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
268,2551,1,1,,11111289,5202,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
269,2551,1,1,,26754231,5202,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
270,2660,1,1,,90341122,5202,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
271,2666,1,1,,90341122,5202,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
272,2667,1,1,,90341122,5202,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
273,2668,1,1,,90341122,5202,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
274,3180,9,2,,103165719,5202,Active,,,0.0059,IC50,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,Confirmatory,8176710.0,
275,3185,7,1,,103165719,5202,Active,,,0.006,IC50,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,Confirmatory,2918500.0,
276,3187,7,1,,103165719,5202,Active,,,0.0028,Ki,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,Confirmatory,2918500.0,
277,3189,5,6,,103165719,5202,Active,2494923.0,100379622.0,0.0052,EC50,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,Confirmatory,1447752.0,
278,3199,3,10,,103165719,5202,Unspecified,6224984.0,100135548.0,,,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,Other,,
279,3200,3,10,,103165719,5202,Unspecified,6224984.0,100135548.0,,,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),Other,,
280,3463,7,1,,103165719,5202,Active,,,0.0056,IC50,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,Confirmatory,2918500.0,
281,3465,7,1,,103165719,5202,Active,,,0.002,IC50,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,Confirmatory,2918500.0,
282,3466,7,1,,103165719,5202,Active,,,0.002,IC50,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,Confirmatory,2918500.0,
283,3486,7,1,,103165719,5202,Active,,,0.003,Ki,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,Confirmatory,2918500.0,
284,3490,8,1,,103165719,5202,Active,,,0.043,EC50,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,Confirmatory,,
285,3492,4,6,,103165719,5202,Active,,,0.01,EC50,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,Confirmatory,1447752.0,
286,3499,7,2,,103165719,5202,Active,,,0.0052,IC50,Binding affinity against 5-hydroxytryptamine 1A receptor,Confirmatory,1447752.0,
287,3502,7,2,,103165719,5202,Active,,,0.03,EC50,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,Confirmatory,2374139.0,
288,3519,8,5,,103165719,5202,Active,231454.0,3350.0,0.0037,EC50,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,Confirmatory,12954071.0,
289,3552,3,7,,103165719,5202,Unspecified,,,,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,Other,14613313.0,
290,3590,8,5,,103165719,5202,Active,231454.0,3350.0,0.0012,IC50,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,Confirmatory,12954071.0,
291,3671,9,1,,103165719,5202,Active,,,0.02,IC50,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,Confirmatory,1354263.0,
292,3695,7,1,,103165719,5202,Active,,,0.002,Ki,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,Confirmatory,3543362.0,
293,3709,8,1,,103165719,5202,Active,,,0.01,EC50,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,Confirmatory,8057297.0,
294,3731,7,2,,103165719,5202,Active,,,0.0052,IC50,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,Confirmatory,8057297.0,
295,3762,7,2,,103165719,5202,Active,,,0.003,IC50,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,Confirmatory,9046348.0,
296,3770,8,5,,103165719,5202,Active,112812.0,24473.0,0.0026,IC50,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,Confirmatory,9357534.0,
297,3771,8,5,,103165719,5202,Active,112812.0,24473.0,0.0052,IC50,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,Confirmatory,2374139.0,
298,3788,3,6,,103165719,5202,Unspecified,,,,,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,Other,14613313.0,
299,3822,7,2,,103165719,5202,Active,,,0.00248,Ki,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,Confirmatory,9871775.0,
300,3829,7,1,,103165719,5202,Active,,,0.0017,Ki,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,Confirmatory,8071931.0,
301,3835,8,1,,103165719,5202,Active,,,0.00248,Ki,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,Confirmatory,8960551.0,
302,3877,5,2,,103165719,5202,Unspecified,,,,,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,Other,14613313.0,
303,3889,3,11,,103165719,5202,Unspecified,231454.0,3350.0,,,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,Other,10514291.0,
304,3890,3,8,,103165719,5202,Unspecified,,,,,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,Other,10425105.0,
305,3895,3,8,,103165719,5202,Unspecified,,,,,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,Other,10425105.0,
306,3898,3,11,,103165719,5202,Unspecified,231454.0,3350.0,,,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,Other,10514291.0,
307,3902,4,1,,103165719,5202,Active,,,0.008709999999999999,EC50,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,Confirmatory,14613313.0,
308,3925,4,1,,103165719,5202,Active,,,0.00398,Ki,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,Confirmatory,14613313.0,
309,3943,8,5,,103165719,5202,Active,231454.0,3350.0,0.0025,Ki,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,Confirmatory,7658447.0,
310,3961,9,5,,103165719,5202,Active,341940152.0,15550.0,0.005,IC50,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,Confirmatory,2136918.0,
311,3964,8,3,,103165719,5202,Inconclusive,,,,,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,Other,2136918.0,
312,4004,7,1,,103165719,5202,Active,,,0.0073,Ki,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,Confirmatory,10229626.0,
313,4035,7,2,,103165719,5202,Active,,,0.0017,Ki,Binding affinity towards 5-hydroxytryptamine 1A receptor,Confirmatory,2965244.0,
314,4036,8,5,,103165719,5202,Active,112812.0,24473.0,0.0043100000000000005,Ki,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,Confirmatory,8230102.0,
315,4043,7,1,,103165719,5202,Active,,,0.002,Ki,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,Confirmatory,2299641.0,
316,4096,7,1,,103165719,5202,Active,,,0.003,Ki,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,Confirmatory,3543362.0,
317,4133,7,2,,103165719,5202,Active,,,0.0052,IC50,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,Confirmatory,,
318,4204,7,1,,103165719,5202,Active,,,0.0073,Ki,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,Confirmatory,9513601.0,
319,4235,7,2,,103165719,5202,Active,,,0.0048,Ki,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,Confirmatory,12519065.0,
320,4244,7,3,,103165719,5202,Active,,,0.0067599999999999995,Ki,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,Confirmatory,9871775.0,
321,4252,8,1,,103165719,5202,Active,,,0.0067599999999999995,Ki,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,Confirmatory,8960551.0,
322,4275,4,1,,103165719,5202,Active,,,0.0050100000000000006,Ki,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,Confirmatory,14613313.0,
323,4290,3,8,,103165719,5202,Unspecified,,,,,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",Other,9548813.0,
324,4365,7,1,,103165719,5202,Active,,,0.0021,Ki,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,Confirmatory,7629808.0,
325,4411,5,1,,103165719,5202,Active,,,0.00479,Ki,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,Confirmatory,8568799.0,
326,4424,4,1,,103165719,5202,Active,,,0.00158,Ki,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,Confirmatory,10543880.0,
327,4455,3,7,,103165719,5202,Unspecified,,,,,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,Other,8515429.0,
328,4495,5,6,,103165719,5202,Active,112821.0,3351.0,0.0048200000000000005,EC50,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,Confirmatory,8960551.0,
329,4502,4,8,,103165719,5202,Active,,,0.0046700000000000005,EC50,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,Confirmatory,9871775.0,
330,4519,3,8,,103165719,5202,Unspecified,,,,,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,Other,9548813.0,
331,4533,7,2,,103165719,5202,Active,,,0.003,IC50,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,Confirmatory,2374139.0,
332,4534,7,3,,103165719,5202,Active,,,0.003,IC50,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,Confirmatory,,
333,4539,7,1,,103165719,5202,Active,,,0.003,Ki,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,Confirmatory,2299641.0,
334,4550,8,5,,103165719,5202,Active,2494923.0,100379622.0,0.0085,EC50,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,Confirmatory,,
335,4557,8,5,,103165719,5202,Active,2494923.0,100379622.0,0.003,IC50,Binding affinity against 5-hydroxytryptamine 1D receptor,Confirmatory,1447752.0,
336,4567,8,5,,103165719,5202,Active,2494923.0,100379622.0,0.016,EC50,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,Confirmatory,2374139.0,
337,4569,7,3,,103165719,5202,Active,,,0.0071,Ki,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,Confirmatory,7658447.0,
338,4583,5,1,,103165719,5202,Active,,,0.0012,ED50,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,Confirmatory,8071931.0,
339,4614,7,2,,103165719,5202,Active,,,0.00506,Ki,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,Confirmatory,9871775.0,
340,4622,8,1,,103165719,5202,Active,,,0.00506,Ki,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,Confirmatory,8960551.0,
341,4627,7,2,,103165719,5202,Active,,,0.002,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,Confirmatory,9986723.0,
342,4666,7,2,,103165719,5202,Active,,,0.026000000000000002,EC50,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,Confirmatory,2374139.0,
343,4679,8,5,,103165719,5202,Active,112815.0,25075.0,0.0046,IC50,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,Confirmatory,9357534.0,
344,4680,7,1,,103165719,5202,Active,,,0.005,IC50,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,Confirmatory,2374139.0,
345,4686,7,2,,103165719,5202,Active,,,0.0011,Ki,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,Confirmatory,9513601.0,
346,4693,7,3,,103165719,5202,Active,,,0.0011,Ki,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,Confirmatory,10229626.0,
347,4697,7,1,,103165719,5202,Active,,,0.005,Ki,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,Confirmatory,2299641.0,
348,4698,7,2,,103165719,5202,Active,,,0.0054,Ki,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,Confirmatory,8071931.0,
349,4699,7,1,,103165719,5202,Active,,,0.025,Ki,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,Confirmatory,3543362.0,
350,4701,7,2,,103165719,5202,Active,,,0.0054,Ki,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,Confirmatory,2965244.0,
351,4709,7,2,,103165719,5202,Active,,,0.0025,Ki,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,Confirmatory,7629808.0,
352,4717,5,1,,103165719,5202,Active,112815.0,25075.0,0.0034700000000000004,Ki,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,Confirmatory,3385733.0,
353,4722,4,1,,103165719,5202,Active,,,0.00251,Ki,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,Confirmatory,10543880.0,
354,4735,7,3,,103165719,5202,Active,,,0.005,IC50,Binding affinity against 5-hydroxytryptamine 1B receptor,Confirmatory,1447752.0,
355,4744,7,2,,103165719,5202,Active,,,0.081,IC50,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,Confirmatory,2374139.0,
356,4747,7,2,,103165719,5202,Active,,,0.035,Ki,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,Confirmatory,3543362.0,
357,4758,8,5,,103165719,5202,Active,112817.0,25187.0,0.01,Ki,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,Confirmatory,2299641.0,
358,4773,7,2,,103165719,5202,Active,,,0.081,IC50,Binding affinity against 5-hydroxytryptamine 1C receptor,Confirmatory,1447752.0,
359,4778,3,7,,103165719,5202,Unspecified,,,,,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,Other,8515429.0,
360,4780,7,2,,103165719,5202,Active,,,0.02,IC50,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,Confirmatory,1447752.0,
361,4781,7,2,,103165719,5202,Active,,,3.6,IC50,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,Confirmatory,1447752.0,
362,4802,7,1,,103165719,5202,Active,,,4.6,IC50,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,Confirmatory,2374139.0,
363,4856,3,7,,103165719,5202,Unspecified,,,,,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,Other,7752204.0,
364,4857,7,1,,103165719,5202,Active,,,0.01,IC50,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,Confirmatory,7752204.0,
365,4862,6,2,,103165719,5202,Active,,,0.01,IC50,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,Confirmatory,,
366,4864,7,1,,103165719,5202,Active,,,0.01,IC50,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,Confirmatory,8496922.0,
367,4872,8,1,,103165719,5202,Active,,,0.0052,EC50,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,Confirmatory,8057297.0,
368,4873,7,2,,103165719,5202,Active,,,0.003,IC50,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,Confirmatory,8057297.0,
369,4883,3,7,,103165719,5202,Unspecified,,,,,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,Other,8515429.0,
370,4896,7,2,,103165719,5202,Active,,,0.0017,Ki,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,Confirmatory,8568822.0,
371,4908,7,2,,103165719,5202,Active,,,0.0048,Ki,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,Confirmatory,7658447.0,
372,4910,8,5,,103165719,5202,Active,112819.0,3352.0,0.0055,Ki,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,Confirmatory,8071931.0,
373,4927,7,3,,103165719,5202,Active,,,0.004,Ki,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,Confirmatory,8568822.0,
374,4929,7,2,,103165719,5202,Active,,,0.004,Ki,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,Confirmatory,8071931.0,
375,4950,7,1,,103165719,5202,Active,,,0.004,Ki,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,Confirmatory,2299641.0,
376,4974,4,6,,103165719,5202,Active,,,0.0079,EC50,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,Confirmatory,11708905.0,
377,4975,3,6,,103165719,5202,Unspecified,,,,,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,Other,11708905.0,
378,5021,9,5,,103165719,5202,Active,543728.0,15558.0,0.68,IC50,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,Confirmatory,2136918.0,
379,5021,9,5,,103165719,5202,Active,341940154.0,15560.0,0.68,IC50,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,Confirmatory,2136918.0,
380,5021,9,5,,103165719,5202,Active,550544258.0,15559.0,0.68,IC50,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,Confirmatory,2136918.0,
381,5023,9,5,,103165719,5202,Active,543728.0,15558.0,0.5,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,Confirmatory,2136918.0,
382,5023,9,5,,103165719,5202,Active,341940154.0,15560.0,0.5,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,Confirmatory,2136918.0,
383,5023,9,5,,103165719,5202,Active,550544258.0,15559.0,0.5,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,Confirmatory,2136918.0,
384,5085,5,1,,103165719,5202,Active,112808.0,29595.0,0.97724,Ki,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,Confirmatory,3385733.0,
385,5085,5,1,,103165719,5202,Active,112817.0,25187.0,0.97724,Ki,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,Confirmatory,3385733.0,
386,5085,5,1,,103165719,5202,Active,398970.0,29581.0,0.97724,Ki,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,Confirmatory,3385733.0,
387,5093,6,2,,103165719,5202,Active,,,0.0106,Ki,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,Confirmatory,3336031.0,
388,5095,6,2,,103165719,5202,Active,,,0.0061,Ki,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,Confirmatory,3336031.0,
389,5097,6,2,,103165719,5202,Active,,,0.6,Ki,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,Confirmatory,3336031.0,
390,5099,3,6,,103165719,5202,Unspecified,,,,,Hill coefficient of compound was determined,Other,3336031.0,
391,5108,7,2,,103165719,5202,Active,,,0.0078,Ki,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",Confirmatory,2965244.0,
392,5109,7,2,,103165719,5202,Active,,,0.93,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,Confirmatory,2965244.0,
393,5126,3,8,,103165719,5202,Unspecified,,,,,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,Other,8515429.0,
394,5158,7,2,,103165719,5202,Active,,,0.0082,Ki,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,Confirmatory,12954071.0,
395,5162,5,6,,103165719,5202,Active,543727.0,3356.0,0.011000000000000001,EC50,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,Confirmatory,15081042.0,
396,5191,8,5,,103165719,5202,Active,543727.0,3356.0,0.013999999999999999,Ki,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,Confirmatory,15081042.0,
397,5201,7,1,,103165719,5202,Active,,,0.51,Ki,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,Confirmatory,8071931.0,
398,5239,7,1,,103165719,5202,Active,,,0.006,Ki,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,Confirmatory,3543362.0,
399,5248,7,1,,103165719,5202,Active,,,0.95,Ki,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,Confirmatory,2299641.0,
400,5270,8,1,,103165719,5202,Active,,,0.56,Ki,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,Confirmatory,3543362.0,
401,5273,7,1,,103165719,5202,Active,,,2.95,Ki,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,Confirmatory,3543362.0,
402,5342,4,1,,103165719,5202,Active,,,1.2589299999999999,Ki,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,Confirmatory,10543880.0,
403,5383,9,2,,103165719,5202,Active,1168220.0,3357.0,0.0015,EC50,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,Confirmatory,15081042.0,
404,5401,3,7,,103165719,5202,Unspecified,,,,,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,Other,15081042.0,
405,5422,4,1,,103165719,5202,Active,,,0.39810999999999996,Ki,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,Confirmatory,14613313.0,
406,5464,5,6,,103165719,5202,Active,112808.0,29595.0,0.35100000000000003,EC50,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,Confirmatory,12954071.0,
407,5468,4,6,,103165719,5202,Active,,,0.0558,EC50,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,Confirmatory,12954071.0,
408,5487,8,5,,103165719,5202,Active,112808.0,29595.0,0.0009,IC50,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,Confirmatory,12954071.0,
409,5489,8,5,,103165719,5202,Active,112808.0,29595.0,2.35,IC50,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,Confirmatory,9357534.0,
410,5571,8,5,,103165719,5202,Active,112808.0,29595.0,0.0003,Ki,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,Confirmatory,12954071.0,
411,5626,8,5,,103165719,5202,Active,112816.0,3358.0,0.0083,Ki,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,Confirmatory,12954071.0,
412,5634,3,10,,103165719,5202,Unspecified,112816.0,3358.0,,,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,Other,15081042.0,
413,5650,4,1,,103165719,5202,Active,,,0.05012,Ki,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,Confirmatory,14613313.0,
414,5707,8,5,,103165719,5202,Active,112817.0,25187.0,0.042,IC50,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,Confirmatory,9357534.0,
415,5729,7,1,,103165719,5202,Active,,,0.023,Ki,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,Confirmatory,8071931.0,
416,5757,4,1,,103165719,5202,Active,,,0.03162,Ki,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,Confirmatory,10543880.0,
417,5764,8,5,,103165719,5202,Active,1168220.0,3357.0,0.012,Ki,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,Confirmatory,15081042.0,
418,5770,8,5,,103165719,5202,Active,1168220.0,3357.0,0.013000000000000001,Ki,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,Confirmatory,12954071.0,
419,5774,3,10,,103165719,5202,Unspecified,1168220.0,3357.0,,,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,Other,15081042.0,
420,5842,5,6,,103165719,5202,Active,112816.0,3358.0,0.0017,EC50,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,Confirmatory,15081042.0,
421,5869,8,5,,103165719,5202,Active,112816.0,3358.0,0.0069,Ki,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,Confirmatory,15081042.0,
422,5878,7,1,,103165719,5202,Active,,,0.32,Ki,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,Confirmatory,8071931.0,
423,5888,7,2,,103165719,5202,Active,,,0.087,Ki,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,Confirmatory,,
424,5893,7,1,,103165719,5202,Active,,,0.12,Ki,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,Confirmatory,9513601.0,
425,5904,7,1,,103165719,5202,Active,,,0.39,Ki,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,Confirmatory,1573641.0,
426,5911,7,1,,103165719,5202,Active,,,0.066,Ki,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,Confirmatory,7629808.0,
427,6008,7,1,,103165719,5202,Active,,,0.361,Ki,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),Confirmatory,2231600.0,
428,6069,7,1,,103165719,5202,Active,,,0.727,IC50,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,Confirmatory,9357534.0,
429,6128,3,6,,103165719,5202,Active,,,,,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,Other,10229626.0,
430,6132,8,5,,103165719,5202,Active,1168223.0,79246.0,0.12,Ki,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,Confirmatory,10229626.0,
431,6132,8,5,,103165719,5202,Active,81868595.0,58963.0,0.12,Ki,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,Confirmatory,10229626.0,
432,6140,5,6,,103165719,5202,Active,6224984.0,100135548.0,0.005,EC50,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,Confirmatory,,
433,6142,5,6,,103165719,5202,Active,6224984.0,100135548.0,0.005,EC50,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",Confirmatory,9046352.0,
434,6153,8,7,,103165719,5202,Inactive,6224984.0,100135548.0,,,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",Other,9046352.0,
435,6172,3,10,,103165719,5202,Unspecified,6224984.0,100135548.0,,,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,Other,7608898.0,
436,6181,8,5,,103165719,5202,Active,6224984.0,100135548.0,0.23,Ki,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,Confirmatory,7629808.0,
437,6184,3,10,,103165719,5202,Unspecified,6224984.0,100135548.0,,,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,Other,7608898.0,
438,6200,4,1,,103165719,5202,Active,6224984.0,100135548.0,0.1,Ki,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,Confirmatory,10543880.0,
439,6223,3,7,,103165719,5202,Unspecified,,,,,lntrinsic activity relative to 5-HT receptor,Other,,
440,6225,8,1,,103165719,5202,Active,,,0.0171,EC50,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,Confirmatory,,
441,6230,5,1,,103165719,5202,Active,,,0.016,ED50,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,Confirmatory,1573641.0,
442,6231,4,7,,103165719,5202,Active,,,0.0037,IC50,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,Confirmatory,,
443,6232,8,5,,103165719,5202,Active,2494928.0,25324.0,0.147,IC50,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,Confirmatory,9357534.0,
444,6239,7,1,,103165719,5202,Active,,,0.187,Ki,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,Confirmatory,9046352.0,
445,6243,7,3,,103165719,5202,Active,,,0.0374,Ki,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,Confirmatory,,
446,6250,4,1,,103165719,5202,Active,,,0.0063100000000000005,EC50,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,Confirmatory,,
447,6297,4,1,,103165719,5202,Active,,,0.39810999999999996,Ki,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,Confirmatory,10543880.0,
448,6315,3,8,,103165719,5202,Unspecified,,,,,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,Other,,
449,6324,3,10,,103165719,5202,Active,,,,,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,Other,12217367.0,
450,6329,3,9,,103165719,5202,Active,,,,,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,Other,12217367.0,
451,6335,7,4,,103165719,5202,Active,,,0.12,Ki,Binding affinity towards 5-hydroxytryptamine 3 receptor,Confirmatory,12217367.0,
452,6346,3,9,,103165719,5202,Unspecified,,,,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,Other,11229746.0,
453,6347,3,9,,103165719,5202,Unspecified,,,,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,Other,11229746.0,
454,6348,3,9,,103165719,5202,Unspecified,,,,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,Other,11229746.0,
455,6349,3,9,,103165719,5202,Unspecified,,,,,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,Other,11229746.0,
456,6350,4,1,,103165719,5202,Active,,,0.14454,Ki,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,Confirmatory,,
457,6380,7,6,,103165719,5202,Active,1168223.0,79246.0,12.0,EC50,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,Confirmatory,15050614.0,
458,6383,4,11,,103165719,5202,Unspecified,6224984.0,100135548.0,,,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,Other,,
459,6480,8,5,,103165719,5202,Active,1345607.0,3361.0,0.126,Ki,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,Confirmatory,12825922.0,
460,6489,8,5,,103165719,5202,Active,341940155.0,15563.0,0.15,Ki,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,Confirmatory,12825922.0,
461,6499,7,3,,103165719,5202,Active,,,0.25,Ki,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,Confirmatory,12825922.0,
462,6514,8,5,,103165719,5202,Active,1703010.0,3362.0,0.065,Ki,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,Confirmatory,12825922.0,
463,6518,7,1,,103165719,5202,Active,,,0.075,Ki,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",Confirmatory,10715164.0,
464,6520,7,1,,103165719,5202,Active,,,0.078,Ki,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,Confirmatory,11055342.0,
465,6536,4,1,,103165719,5202,Active,,,0.12589,Ki,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,Confirmatory,14613313.0,
466,6587,8,5,,103165719,5202,Active,8488960.0,3363.0,0.0081,Ki,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,Confirmatory,12825922.0,
467,6611,4,1,,103165719,5202,Active,,,0.00316,Ki,Binding affinity against 5-hydroxytryptamine 7 human receptors,Confirmatory,14613313.0,
468,6648,7,2,,103165719,5202,Active,,,0.01,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,Confirmatory,12825922.0,
469,6666,4,1,,103165719,5202,Active,,,0.000603,Ki,Binding affinity at rat 5-hydroxytryptamine 7 receptor.,Confirmatory,14640545.0,
470,6673,5,7,,103165719,5202,Active,461440.0,65032.0,,,Agonistic activity against rat 5-HT7-adenyl cyclase expressed by HEK293 cells; Active,Other,14640545.0,
471,6678,7,2,,103165719,5202,Active,,,0.004,Ki,Binding affinity of compound towards rodent 5-hydroxytryptamine 7 receptor,Confirmatory,12825922.0,
472,15660,4,1,,103165719,5202,Unspecified,,,,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Other,8176710.0,
473,19560,3,4,,103165719,5202,Unspecified,,,,,Hill coefficient of the compound,Other,8230102.0,
474,37023,3,7,,103165719,5202,Unspecified,,,,,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]-prazosin binding to Alpha-1 adrenergic receptor in rat cortical membrane,Other,9046348.0,
475,42015,8,6,,103165719,5202,Inconclusive,,,,,In vitro displacement of [3H]flunitrazepam from GABA-A central benzodiazepine receptor of guinea pig cerebellum (not tested),Other,,
476,52379,3,5,,103165719,5202,Unspecified,,,,,Hill number was determined for inhibition of [3H]ketanserin binding in mouse cerebral cortex,Other,2136918.0,
477,61865,8,5,,103165719,5202,Active,118228.0,1812.0,9.69,Kd,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,Confirmatory,8632409.0,
478,61867,3,9,,103165719,5202,Unspecified,118228.0,1812.0,,,log(1/Kd) value against recombinant Dopamine receptor D1A expressed in COS7 cell,Other,8632409.0,
479,61996,3,9,,103165719,5202,Active,118229.0,24316.0,,,Low-affinity agonist dissociation constant against striatal Dopamine receptor D1A,Other,8632409.0,
480,62635,5,4,,103165719,5202,Active,,,3e-07,IC50,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,Confirmatory,3156993.0,
481,63230,3,6,,103165719,5202,Unspecified,,,,,Binding affinity against human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride,Other,14613313.0,
482,64788,3,9,,103165719,5202,Unspecified,47117674.0,24318.0,,,Low-affinity agonist dissociation constant against striatal Dopamine receptor D2,Other,8632409.0,
483,65625,7,1,,103165719,5202,Active,,,2.338,Ki,Tested for binding affinity against dopamine receptor D3 expressed in Sf9 cells.,Confirmatory,8098771.0,
484,65768,7,1,,103165719,5202,Active,,,,,Maximal stimulation reached was evaluated by using [35S]- GTP-gamma S radioligand,Other,12930145.0,
485,65769,7,2,,103165719,5202,Active,,,0.523,EC50,Basal binding towards Dopamine receptor D3 was evaluated using [35S]- GTP-gamma S radioligand,Confirmatory,12930145.0,
486,88608,3,6,,103165719,5202,Unspecified,,,,,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding in mouse hippocampus,Other,2136918.0,
487,107885,12,2,,103165719,5202,Unspecified,1346544.0,4543.0,100.0,Ki,Displacement of 2-[125I]iodomelatonin from human Melatonin receptor type 1A expressed in CHO cells,Confirmatory,,
488,108050,8,5,,103165719,5202,Unspecified,1346548.0,4544.0,100.0,Ki,Inhibition of 2-[125I]iodomelatonin binding to human Melatonin receptor type 1B expressed in CHO cells,Confirmatory,,
489,143659,4,5,,103165719,5202,Active,,,0.293,EC50,In Vitro 5-HT3 agonist activity on the [14C]guanidinium accumulation in NG 108-15 cells.,Confirmatory,9191957.0,
490,143663,4,4,,103165719,5202,Active,,,0.298,EC50,Quantitative effect on the [14C]guanidinium accumulation in NG 108-15 cells.,Confirmatory,10229626.0,
491,165751,3,3,,103165719,5202,Unspecified,,,,,Maximum vein contraction obtained relative to 5-hydroxytryptamine,Other,7658447.0,
492,165753,3,3,,103165719,5202,Unspecified,,,,,"The compound was tested for functional activity by measuring the contraction of saphenous vein from New Zealand white rabbit,",Other,7658447.0,
493,165754,5,2,,103165719,5202,Active,,,0.15849000000000002,EC50,Functional activity was determined by the contraction of New Zealand white rabbit saphenous vein.,Confirmatory,7752204.0,
494,166998,3,1,,103165719,5202,Active,,,0.15849000000000002,EC50,Compound was tested for the contraction of New Zealand white rabbit saphenous vein,Confirmatory,,
495,167003,5,2,,103165719,5202,Active,,,0.15849000000000002,EC50,Serotonergic activity was assessed in vitro on the New Zealand white rabbit saphenous vein preparation,Confirmatory,8496922.0,
496,167020,3,3,,103165719,5202,Unspecified,,,,,Relative maximum is the relative efficacy with respect to 1 uM 5-HT,Other,8496922.0,
497,180155,4,3,,103165719,5202,Active,,,0.369,IC50,Inhibitory activity for 5-HT uptake was determined using [3H]- Citalopram,Confirmatory,9357534.0,
498,186263,2,4,,103165719,5202,Unspecified,,,,,Tested for maximum response in depolarization of isolated rat vagus nerve measured at dose 10 uM,Other,,
499,186654,3,3,,103165719,5202,Unspecified,,,,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Other,8176710.0,
500,187178,4,3,,103165719,5202,Unspecified,,,5.0,Ki,Inhibition constant of compound on R-(+)-125[I]-8 radioligand binding to rat striatal membranes,Confirmatory,1825848.0,
501,193608,6,1,,103165719,5202,Unspecified,,,,,Effect of direct injection into the PVN (paraventricular medial hypothalamus) of rats on feeding behavior and the inhibition of food intake,Other,2374139.0,
502,196435,4,3,,103165719,5202,Unspecified,,,5.0,Ki,Inhibition constant on radiolabeled [125 I] FIDA1 binding to rat striatal membranes,Confirmatory,8093734.0,
503,196436,4,3,,103165719,5202,Unspecified,,,3.0,Ki,Inhibition constant on radiolabeled [125 I] FIDA2 binding to rat striatal membranes,Confirmatory,8093734.0,
504,196752,8,2,,103165719,5202,Active,,,3.5481300000000005,IC50,Compound was evaluated for its activity at membrane-bound receptor (M+L+P fraction) from rat frontal cortex,Confirmatory,3746815.0,
505,196753,8,2,,103165719,5202,Active,,,28.1838,IC50,Compound was evaluated for its activity at solubilized receptor (CHAPS/salt-solubilized preparation) from rat frontal cortex,Confirmatory,3746815.0,
506,196754,4,3,,103165719,5202,Active,,,0.919,Ki,Compound was evaluated for its activity at membrane-bound receptor (M+L+P fraction) from rat frontal cortex,Confirmatory,3746815.0,
507,196755,4,3,,103165719,5202,Active,,,14.092,Ki,Compound was evaluated for its activity at solubilized receptor (CHAPS/salt-solubilized preparation) from rat frontal cortex,Confirmatory,3746815.0,
508,197364,3,1,,103165719,5202,Active,,,0.97724,EC50,Tested for effective concentration against 5-HT mediated depolarization of isolated rat vagus nerve,Confirmatory,,
509,204521,7,2,,103165719,5202,Active,,,0.74,Ki,Ability to displace [3H]paroxetine bound to Serotonin transporter receptor in rat forebrain,Confirmatory,9513601.0,
510,204548,7,2,,103165719,5202,Active,,,0.74,Ki,Binding affinity towards Serotonin transporter was determined in rat forebrain membrane,Confirmatory,10229626.0,
511,218766,6,2,,103165719,5202,Active,,,0.21,EC50,In vitro evaluation in the dog saphenous vein for maximal response,Confirmatory,8515429.0,
512,218767,3,3,,103165719,5202,Unspecified,,,,,Intrinsic activity was measured as maximum contraction relative to 5-HT in dog saphenous vein,Other,8515429.0,
513,220762,3,3,,103165719,5202,Unspecified,,,,,Intrinsic activity was measured as maximum contraction relative to 5-HT in rabbit basilar artery,Other,8515429.0,
514,224186,6,2,,103165719,5202,Active,,,0.3,EC50,In vitro evaluation in rabbit basilar artery for maximal response,Confirmatory,8515429.0,
515,226638,3,3,,103165719,5202,Unspecified,,,,,Hill coefficient value.,Other,8098771.0,
516,227718,7,1,,103165719,5202,Unspecified,,,,,Binding energy by using the equation deltaG obsd = -RT ln KD,Other,6094812.0,
517,230153,3,3,,103165719,5202,Unspecified,,,,,The compound was evaluated for equipotent concentration ratio (ECR) where ECR = IC40 test agonist / IC40 5-HT,Other,8176710.0,
518,231292,3,6,,103165719,5202,Unspecified,,,,,Ratio of binding affinity of 5-HT1A receptor to that of 5-HT1D receptor,Other,,
519,232379,3,6,,103165719,5202,Unspecified,,,,,Ratio of EC50 of 5-HT1A receptor to that of 5-HT1D receptor,Other,,
520,234962,3,7,,103165719,5202,Unspecified,,,,,Selectivity at 5-hydroxytryptamine 1D receptor beta compared to 5-hydroxytryptamine 1D receptor alpha.,Other,8568822.0,
521,235510,3,5,,103165719,5202,Unspecified,,,,,Selectivity value is the ratio between EC50 values of 5-HT1A and 5-HT1D receptors,Other,8057297.0,
522,235511,3,5,,103165719,5202,Unspecified,,,,,Selectivity value is the ratio between IC50 values of 5-HT1A and 5-HT1D receptors,Other,8057297.0,
523,238017,3,10,,103165719,5202,Unspecified,231454.0,3350.0,,,"Intrinsic activity for human 5-hydroxytryptamine 1A receptor in [35S]GTP-gamma-S, assay; full agonist",Other,15887956.0,
524,238018,3,9,,103165719,5202,Unspecified,112821.0,3351.0,,,"Intrinsic activity for human 5-hydroxytryptamine 1B receptor in [35S]GTP-gamma-S, assay; full agonist",Other,15887956.0,
525,238019,3,10,,103165719,5202,Unspecified,112819.0,3352.0,,,"Intrinsic activity for human 5-hydroxytryptamine 1D receptor in [35S]GTP-gamma-S, assay; full agonist",Other,15887956.0,
526,238424,8,5,,103165719,5202,Active,1703010.0,3362.0,0.1,Ki,Binding affinity against 5-hydroxytryptamine 6 receptor,Confirmatory,15357994.0,
527,255079,8,5,,103165719,5202,Active,803374855.0,140.0,0.079,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,Confirmatory,16250647.0,
528,258784,5,2,,103165719,5202,Unspecified,,,,,Half life in phosphate buffer at pH 7.4 in 45 degC,Other,16392816.0,
529,258785,8,5,,103165719,5202,Active,112808.0,29595.0,0.0009400000000000001,IC50,Inhibition of [125I]DOI binding to 5HT2A receptor in rat cerebral cortex,Confirmatory,16392816.0,
530,258786,5,6,,103165719,5202,Unspecified,112808.0,29595.0,,EC50,Activity against 5HT2A mediated intracellular calcium mobilization by FLIPR in rat vascular smooth muscle cells,Confirmatory,16392816.0,
531,258787,5,6,,103165719,5202,Active,398970.0,29581.0,0.0035,EC50,Activity against 5HT2B receptor in longitudinal stomach fundus strips in wistar rats,Confirmatory,16392816.0,
532,258788,5,6,,103165719,5202,Unspecified,112817.0,25187.0,,EC50,Activity against recombinant rat 5HT2C mediated intracellular calcium mobilization by FLIPR in SR3T3 cells,Confirmatory,16392816.0,
533,258789,8,5,,103165719,5202,Active,543727.0,3356.0,0.0082,Ki,Displacement of [125I]DOI from cloned human 5HT2A receptor expressed in CHO cells,Confirmatory,16392816.0,
534,258790,8,5,,103165719,5202,Active,1168220.0,3357.0,0.013000000000000001,Ki,Displacement of [125I]DOI from cloned human 5HT2B receptor expressed in CHO cells,Confirmatory,16392816.0,
535,258791,8,5,,103165719,5202,Active,112816.0,3358.0,0.0083,Ki,Displacement of [125I]DOI from cloned human 5HT2C receptor expressed in CHO cells,Confirmatory,16392816.0,
536,259335,9,1,,103165719,5202,Active,231454.0,3350.0,0.0005,EC50,Agonistic activity at human 5HT1A receptor by [35S]GTP-gamma-S binding,Confirmatory,16392798.0,
537,259336,5,6,,103165719,5202,Active,231454.0,3350.0,0.001,EC50,Agonistic activity at human 5HT1A in CHO cells by the inhibition of forskolin-stimulated cAMP accumulation,Confirmatory,16392798.0,
538,259790,3,10,,103165719,5202,Unspecified,543727.0,3356.0,,,Binding to human 5HT2A receptor expressed in CHO cells relative to 5HT,Other,16257207.0,
539,259791,3,10,,103165719,5202,Unspecified,1168220.0,3357.0,,,Binding to human 5HT2B receptor expressed in CHO cells relative to 5HT,Other,16257207.0,
540,259792,3,10,,103165719,5202,Unspecified,112816.0,3358.0,,,Binding to human 5HT2C receptor expressed in CHO cells relative to 5HT,Other,16257207.0,
541,259793,8,5,,103165719,5202,Active,543727.0,3356.0,0.011000000000000001,EC50,Binding to human 5HT2A receptor expressed in CHO cells,Confirmatory,16257207.0,
542,259794,8,5,,103165719,5202,Active,1168220.0,3357.0,0.0015,EC50,Binding to human 5HT2B receptor expressed in CHO cells,Confirmatory,16257207.0,
543,259795,8,5,,103165719,5202,Active,112816.0,3358.0,0.0017,EC50,Binding to human 5HT2C receptor expressed in CHO cells,Confirmatory,16257207.0,
544,259796,8,5,,103165719,5202,Active,543727.0,3356.0,0.013999999999999999,Ki,Displacement of [125I]DOI from human 5HT2A,Confirmatory,16257207.0,
545,259797,8,5,,103165719,5202,Active,1168220.0,3357.0,0.012,Ki,Displacement of [3H]5-HT from human 5HT2B,Confirmatory,16257207.0,
546,259798,8,5,,103165719,5202,Active,112816.0,3358.0,0.0069,Ki,Displacement of [3H]5-HT from human 5HT2C,Confirmatory,16257207.0,
547,263582,9,1,,103165719,5202,Active,231454.0,3350.0,0.0007,EC50,Agonist activity assessed by stimulation of [35S]GTP-gamma-S binding to human 5HT1A receptor expressed in CHO cells,Confirmatory,16458504.0,
548,263867,6,7,,103165719,5202,Unspecified,267045.0,,1200.0,Km,Binding affinity to Catharanthus roseus strictosidine synthase,Confirmatory,16481164.0,
549,268620,7,1,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 by CO2 hydrase assay,Other,16730978.0,
550,268621,7,1,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 by CO2 hydrase assay,Other,16730978.0,
551,268622,7,1,,103165719,5202,Active,30580372.0,71934.0,,,Activation of mouse recombinant CA13 by CO2 hydrase method,Other,16730978.0,
552,291061,7,1,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 by CO2 hydrase assay,Other,17540561.0,
553,291063,7,1,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 by CO2 hydrase assay,Other,17540561.0,
554,291065,7,1,,103165719,5202,Active,1168744.0,766.0,,,Activation of human recombinant CA7 by CO2 hydrase assay,Other,17540561.0,
555,291067,7,1,,103165719,5202,Active,8928036.0,23632.0,,,Activation of of human recombinant CA14 by CO2 hydrase assay,Other,17540561.0,
556,295452,3,11,,103165719,5202,Unspecified,24211440.0,100135547.0,,,Intrinsic activity at 5HT3 receptor in Hartley guinea-pig ileum assessed as muscle contraction relative to 5-hydroxytryptamine,Other,17391967.0,
557,295453,3,11,,103165719,5202,Unspecified,24211440.0,100135547.0,,,Agonist activity at 5HT3 receptor in Hartley guinea-pig ileum assessed as muscle contraction,Other,17391967.0,
558,297967,10,2,,103165719,5202,Inconclusive,2506127.0,1139.0,,IC50,Antagonist activity at human alpha-7 nAChR in tsA201 cells coexpressed with Ric3 by FMP assay,Confirmatory,17722904.0,
559,297968,9,1,,103165719,5202,Inconclusive,,,,IC50,Antagonist activity at rat alpha3beta4 nAChR expressed in HEK293 cells by FMP assay,Confirmatory,17722904.0,
560,297969,10,2,,103165719,5202,Active,1168222.0,3359.0,,IC50,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,Confirmatory,17722904.0,
561,297970,9,1,,103165719,5202,Inconclusive,,,,IC50,Antagonist activity at human rho1 GABAc receptor in HEK293 cells by FMP assay,Confirmatory,17722904.0,
562,297971,10,2,,103165719,5202,Inconclusive,116242495.0,2741.0,,IC50,Antagonist activity at human glycine alpha-1 receptor in HEK293 cells by FMP assay,Confirmatory,17722904.0,
563,298092,3,9,,103165719,5202,Unspecified,112812.0,24473.0,,,Binding affinity to 5HT1A receptor in rat cortex membrane,Other,17803293.0,
564,298093,5,1,,103165719,5202,Active,231454.0,3350.0,0.22909000000000002,EC50,Agonist activity at human 5HT1A receptor expressed in C6 cells assessed as stimulation of [35S]GTPgammaS binding,Confirmatory,17803293.0,
565,305776,7,1,,103165719,5202,Active,461680.0,763.0,,,Activation of human recombinant carbonic anhydrase 5A by stopped-flow CO2 hydrase method,Other,17174092.0,
566,305777,7,1,,103165719,5202,Active,8928041.0,11238.0,,,Activation of human recombinant carbonic anhydrase 5B by stopped-flow CO2 hydrase method,Other,17174092.0,
567,307896,7,1,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped flow CO2 hydrase method,Other,17499996.0,
568,307897,7,1,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 by stopped flow CO2 hydrase method,Other,17499996.0,
569,307898,7,1,,103165719,5202,Active,116241278.0,765.0,,,Activation of human recombinant CA6 by stopped flow CO2 hydrase method,Other,17499996.0,
570,308129,7,1,,103165719,5202,Active,,,0.00733,Ki,Displacement of [3H]LSD from rat recombinant 5HT7 receptor expressed in HEK293 cells at 10 uM,Confirmatory,17517509.0,
571,312492,5,1,,103165719,5202,Active,543727.0,3356.0,0.12589,EC50,Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation,Confirmatory,18095642.0,
572,312493,5,1,,103165719,5202,Active,112816.0,3358.0,0.02512,EC50,Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation,Confirmatory,18095642.0,
573,312494,5,1,,103165719,5202,Active,1168220.0,3357.0,0.02512,EC50,Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as intracellular IP3 accumulation,Confirmatory,18095642.0,
574,312510,3,3,,103165719,5202,Unspecified,,,,,Selectivity ratio of pEC50 for human 5HT2A to pEC50 for human 5HT2C,Other,18095642.0,
575,312511,3,3,,103165719,5202,Unspecified,,,,,Selectivity ratio of pEC50 for human 5HT2B to pEC50 for human 5HT2C,Other,18095642.0,
576,318343,7,1,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped-flow CO2 hydration method,Other,18294854.0,
577,318344,7,1,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 by stopped-flow CO2 hydration method,Other,18294854.0,
578,318345,7,1,,103165719,5202,Active,83300925.0,768.0,,,Activation of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method,Other,18294854.0,
579,318346,7,1,,103165719,5202,Active,5915866.0,771.0,,,Activation of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method,Other,18294854.0,
580,324623,5,6,,103165719,5202,Active,112816.0,3358.0,0.024,EC50,Agonist activity at human cloned 5HT2C receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis,Confirmatory,18035544.0,
581,324624,5,6,,103165719,5202,Active,543727.0,3356.0,0.07,EC50,Agonist activity at human cloned 5HT2A receptor expressed in CHO cells assessed as myo-[3H]inositol hydrolysis,Confirmatory,18035544.0,
582,324625,5,6,,103165719,5202,Active,1168220.0,3357.0,0.0058,EC50,Agonist activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as myo-[3H]inositol hydrolysis,Confirmatory,18035544.0,
583,324626,3,10,,103165719,5202,Unspecified,112816.0,3358.0,,,Intrinsic activity at human cloned 5HT2C receptor expressed in CHO cells assessed as maximal stimulation of 10 uM 5HT-induced myo-[3H]inositol hydrolysis,Other,18035544.0,
584,324627,3,10,,103165719,5202,Unspecified,543727.0,3356.0,,,Intrinsic activity at human cloned 5HT2A receptor expressed in CHO cells assessed as maximal stimulation of 10 uM 5HT-induced myo-[3H]inositol hydrolysis,Other,18035544.0,
585,324628,3,9,,103165719,5202,Unspecified,1168220.0,3357.0,,,Intrinsic activity at human cloned 5HT2B receptor expressed in HEK293-EBNA cells assessed as maximal stimulation of 10 uM 5HT-induced myo-[3H]inositol hydrolysis,Other,18035544.0,
586,324629,3,3,,103165719,5202,Unspecified,,,,,Selectivity ratio of EC50 for human cloned 5HT2C receptor over EC50 for human cloned 5HT2A receptor,Other,18035544.0,
587,324630,3,3,,103165719,5202,Unspecified,,,,,Selectivity ratio of EC50 for human cloned 5HT2B receptor over EC50 for human cloned 5HT2C receptor,Other,18035544.0,
588,330662,3,3,,103165719,5202,Unspecified,,,,,Effect on life span of Caenorhabditis elegans at 1000 uM,Other,18033297.0,
589,330663,3,3,,103165719,5202,Unspecified,,,,,Effect on life span of Caenorhabditis elegans at 3000 uM,Other,18033297.0,
590,330732,9,1,,103165719,5202,Active,,,0.1,EC50,Activity at SER4 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay,Confirmatory,18033297.0,
591,335975,3,4,,103165719,5202,Active,,,,,Effect on Biomphalaria glabrata esophageal rhythmicity assessed as increase in phasic contraction in relaxation phase at 1.92 x 10'-8 to 4 x 10'-7 M,Other,,
592,335976,3,4,,103165719,5202,Inactive,,,,,Effect on Biomphalaria glabrata esophageal rhythmicity assessed as tissue contraction in presence of 8.5 to 320 nM cyproheptadine,Other,,
593,335977,3,4,,103165719,5202,Active,,,,,Effect on Biomphalaria glabrata esophageal rhythmicity assessed as potentiation in amplitude of contraction at 4.8 x 10'-10 M,Other,,
594,335978,3,5,,103165719,5202,Active,,,,,Effect on Biomphalaria glabrata intestinal rhythmicity assessed as potentiation in amplitude of contraction at 4.8 x 10'-10 M,Other,,
595,336182,3,4,,103165719,5202,Active,,,,,Effect on Biomphalaria glabrata esophageal rhythmicity assessed as increase in contraction at 1.0 x 10'-7 to 9.6 x 10'-6 M,Other,,
596,336183,3,5,,103165719,5202,Active,,,,,Effect on Biomphalaria glabrata intestinal rhythmicity assessed as increase in contraction at 1.2 x 10'-6 to 1.9 x 10'-5 M,Other,,
597,336184,3,5,,103165719,5202,Inactive,,,,,Effect on Biomphalaria glabrata intestinal rhythmicity assessed as tissue contraction in presence of 8.5 to 320 nM cyproheptadine,Other,,
598,336185,3,4,,103165719,5202,Inactive,,,,,Effect on Biomphalaria glabrata esophageal rhythmicity assessed as tissue contraction in presence of 8.5 to 320 nM methysergide,Other,,
599,336186,3,5,,103165719,5202,Inactive,,,,,Effect on Biomphalaria glabrata intestinal rhythmicity assessed as tissue contraction in presence of 8.5 to 320 nM methysergide,Other,,
600,337779,10,1,,103165719,5202,Unspecified,,,,,Contractile activity in rabbit celiac artery,Other,1791481.0,
601,337780,10,1,,103165719,5202,Unspecified,,,,,Contractile activity in rabbit mesenteric artery,Other,1791481.0,
602,337781,3,4,,103165719,5202,Unspecified,,,,,Contractile activity in rabbit celiac arteries relative to control,Other,1791481.0,
603,337782,3,4,,103165719,5202,Unspecified,,,,,Contractile activity in rabbit mesenteric arteries relative to control,Other,1791481.0,
604,337783,3,4,,103165719,5202,Active,,,,,Vasorelaxant activity against PGF2-alpha-induced contraction in endothelium-intact rabbit aortic rings up to 40 nmol,Other,1791481.0,
605,337784,3,4,,103165719,5202,Active,,,,,Contractile activity in endothelium-intact rabbit aortic rings at >40 nmol to 400 nmol,Other,1791481.0,
606,337785,3,4,,103165719,5202,Inactive,,,,,Vasorelaxant activity against PGF2-alpha-induced contraction in endothelium-denuded rabbit aortic rings at 0.04 to 400 nmol,Other,1791481.0,
607,337897,4,4,,103165719,5202,Active,,,0.0046,Ki,Displacement of [3H]5HT from 5HT1 receptor,Confirmatory,8496700.0,
608,337898,4,4,,103165719,5202,Active,,,0.531,Ki,Displacement of [3H]ketanserin from 5HT2 receptor,Confirmatory,8496700.0,
609,338181,3,4,,103165719,5202,Unspecified,,,,,Displacement of [3H]5HT from 5HT1 receptor assessed as specific binding relative to total binding,Other,8496700.0,
610,338182,3,4,,103165719,5202,Unspecified,,,,,Displacement of [3H]ketanserin from 5HT2 receptor assessed as specific binding relative to total binding,Other,8496700.0,
611,338923,9,5,,103165719,5202,Active,543727.0,3356.0,0.32,Ki,Displacement of [3H]methylspiperone form human cloned 5HT2A receptor expressed in african green monkey COS7 cells by scintillation spectroscopy,Confirmatory,11975483.0,
612,338924,9,5,,103165719,5202,Active,112816.0,3358.0,0.13,Ki,Displacement of [3H]mesulergine form human cloned 5HT2C receptor expressed in african green monkey COS7 cells by scintillation spectroscopy,Confirmatory,11975483.0,
613,340262,7,3,,103165719,5202,Active,,,0.016,IC50,Inhibition of 5HT1B receptor,Confirmatory,18588282.0,
614,340265,8,5,,103165719,5202,Active,1345607.0,3361.0,0.184,IC50,Inhibition of human 5HT5A receptor,Confirmatory,18588282.0,
615,340266,8,5,,103165719,5202,Active,1703010.0,3362.0,0.262,IC50,Inhibition of human 5HT6 receptor,Confirmatory,18588282.0,
616,340267,8,5,,103165719,5202,Active,8488960.0,3363.0,0.0015,IC50,Inhibition of human 5HT7 receptor,Confirmatory,18588282.0,
617,343011,3,9,,103165719,5202,Unspecified,112812.0,24473.0,,,Agonist activity at 5HT1A receptor in CRL:CD(SD)BR-COBS rat hippocampus assessed as increase in [35S]GTPgammaS binding relative to 5-hydroxytryptamine,Other,18598015.0,
618,343012,9,1,,103165719,5202,Active,112812.0,24473.0,0.32299999999999995,EC50,Agonist activity at 5HT1A receptor in CRL:CD(SD)BR-COBS rat hippocampus assessed as increase in [35S]GTPgammaS binding,Confirmatory,18598015.0,
619,343742,4,10,,103165719,5202,Inconclusive,118228.0,1812.0,,,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells at 10 uM,Other,18562201.0,
620,343743,8,5,,103165719,5202,Inconclusive,118228.0,1812.0,,Ki,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells,Confirmatory,18562201.0,
621,343744,4,10,,103165719,5202,Inconclusive,118206.0,1813.0,,,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells at 10 uM,Other,18562201.0,
622,343745,8,5,,103165719,5202,Inconclusive,118206.0,1813.0,,Ki,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,Confirmatory,18562201.0,
623,343746,4,10,,103165719,5202,Unspecified,112812.0,24473.0,,,Displacement of [3H]8-OH-DPAT from rat 5HT1A receptor expressed in CHO cells at 10 uM,Other,18562201.0,
624,343747,8,5,,103165719,5202,Active,112812.0,24473.0,0.003,Ki,Displacement of [3H]8-OH-DPAT from rat 5HT1A receptor expressed in CHO cells,Confirmatory,18562201.0,
625,346452,8,7,,103165719,5202,Active,112821.0,3351.0,,IC50,Displacement of radiolabeled serotonin from human 5HT1B receptor,Confirmatory,18983139.0,
626,346457,8,7,,103165719,5202,Active,1345607.0,3361.0,,IC50,Displacement of radiolabeled serotonin from human 5HT5A receptor,Confirmatory,18983139.0,
627,346458,8,7,,103165719,5202,Active,1703010.0,3362.0,,IC50,Displacement of radiolabeled serotonin from human 5HT6 receptor,Confirmatory,18983139.0,
628,346459,8,7,,103165719,5202,Active,8488960.0,3363.0,,IC50,Displacement of radiolabeled serotonin from human 5HT7 receptor,Confirmatory,18983139.0,
629,350218,3,4,,103165719,5202,Unspecified,,,,,"Octanol-water partition coefficient, log PC of the compound",Other,19397318.0,
630,350219,3,4,,103165719,5202,Unspecified,,,,,"Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 95% acetonitrile as mobile phase",Other,19397318.0,
631,350220,3,4,,103165719,5202,Unspecified,,,,,"Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 100% water as mobile phase",Other,19397318.0,
632,355721,11,2,,103165719,5202,Active,8488960.0,3363.0,0.00255,IC50,Displacement of [3H]LSD from human 5HT7 receptor expressed in CHO cells,Confirmatory,12713409.0,
633,365827,7,1,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
634,365828,7,1,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
635,365829,7,1,,103165719,5202,Active,134047703.0,761.0,,,Activation of human recombinant CA3 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
636,365830,7,1,,103165719,5202,Active,115465.0,762.0,,,Activation of human recombinant truncated CA4 at 10 uM by stopped-flow CO2 hydration method,Other,18627905.0,
637,375322,8,5,,103165719,5202,Active,112812.0,24473.0,0.0016,Ki,Displacement of [3H]8-OHDPAT from 5HT1A receptor in rat hippocampus,Confirmatory,19425598.0,
638,375323,8,5,,103165719,5202,Active,112808.0,29595.0,1.258,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in rat cortex,Confirmatory,19425598.0,
639,375324,8,5,,103165719,5202,Active,6224984.0,100135548.0,0.1,Ki,Displacement of [3H]GR-113808 from 5HT4 receptor in guinea pig striatum,Confirmatory,19425598.0,
640,375330,3,11,,103165719,5202,Unspecified,24211440.0,100135547.0,,,Agonist activity at 5HT3 receptor in voltage-stimulated guinea pig left atrium assessed as positive inotropic potency,Other,19425598.0,
641,375333,3,11,,103165719,5202,Unspecified,24211440.0,100135547.0,,,Agonist activity at 5HT3 receptor in spontaneously beating guinea pig right atrium assessed as positive chronotropic potency,Other,19425598.0,
642,375336,3,11,,103165719,5202,Unspecified,24211440.0,100135547.0,,,Agonist activity at 5HT3 receptor in guinea pig thoracic aorta assessed as positive contractility potency,Other,19425598.0,
643,375786,7,1,,103165719,5202,Active,115465.0,762.0,,,Activation of human recombinant carbonic anhydrase 4 lacking 20 amino terminal residues by stopped-flow CO2 hydrase method,Other,19464888.0,
644,375787,7,1,,103165719,5202,Active,30580362.0,80733.0,,,Activation of membrane associated mouse recombinant carbonic anhydrase 15 isoform by stopped-flow CO2 hydrase method,Other,19464888.0,
645,378827,9,5,,103165719,5202,Active,543727.0,3356.0,0.69,Ki,Displacement of [N-methyl-3H]LSD from human 5HT2A receptor expressed in HEK293 cells,Confirmatory,17067154.0,
646,378828,9,5,,103165719,5202,Active,112816.0,3358.0,0.02,Ki,Displacement of [N-methyl-3H]LSD from human 5HT2C receptor expressed in HEK293 cells,Confirmatory,17067154.0,
647,378830,9,5,,103165719,5202,Active,12644029.0,3360.0,0.5,Ki,Displacement of [N-methyl-3H]GR-113808 from human 5HT4 receptor expressed in HEK293 cells,Confirmatory,17067154.0,
648,386310,7,1,,103165719,5202,Active,,,,,Inhibition of 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT S277 mutant assessed as drug level causing half maximal protection from inactivation,Other,17698848.0,
649,386313,3,4,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT G273C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
650,386316,3,4,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT S277C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
651,386317,3,4,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT V281C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
652,386318,3,4,,103165719,5202,Inactive,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT T284C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
653,386319,3,4,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT K272C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
654,386320,3,4,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT T276C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
655,386321,3,3,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT W828C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
656,386322,3,4,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT Y107C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
657,386323,3,4,,103165719,5202,Active,,,,,Effect on 2-(aminoethyl)methanethiosulphonate hydrobromide-induced inactivation of rat SERT S404C mutant assessed as increase in rate constant for inactivation,Other,17698848.0,
658,391758,3,10,,103165719,5202,Unspecified,231454.0,3350.0,,,Agonist activity at human cloned 5HT1A receptor expressed in human HeLa cell membrane assessed as stimulation of [35S]GTPgammaS binding,Other,18817363.0,
659,392880,8,1,,103165719,5202,Unspecified,,,,,Antimicrobial activity against Candida albicans ATCC 10231,Other,19167886.0,
660,392881,10,6,,103165719,5202,Unspecified,13123962.0,,301.3,IC50,Inhibition of Candida albicans isocitrate lyase,Confirmatory,19167886.0,
661,404702,8,5,,103165719,5202,Active,112821.0,3351.0,0.0011,Ki,Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1B receptor expressed in CHOK1 cells by liquid scintillation counting,Confirmatory,18507369.0,
662,404703,8,5,,103165719,5202,Active,112819.0,3352.0,,IC50,Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1D receptor expressed in CHOK1 cells by liquid scintillation counting,Confirmatory,18507369.0,
663,404704,4,3,,103165719,5202,Active,,,0.035,Ki,Displacement of [3H]5-hydroxytryptamine from rhesus monkey cloned 5HT1F receptor expressed in African green monkey COS7 cells by liquid scintillation counting,Confirmatory,18507369.0,
664,408275,8,5,,103165719,5202,Active,231454.0,3350.0,0.00126,Ki,Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor,Confirmatory,18433113.0,
665,408276,8,5,,103165719,5202,Active,231454.0,3350.0,10.0,Ki,Displacement of [3H]WAY100635 from human recombinant 5HT1A receptor,Confirmatory,18433113.0,
666,408280,3,10,,103165719,5202,Unspecified,231454.0,3350.0,,,Intrinsic activity at human recombinant 5HT1A receptor expressed in HEK293 cells by [35S]GTPgammaS binding relative to 5 hydroxytryptamine,Other,18433113.0,
667,408464,8,5,,103165719,5202,Active,543727.0,3356.0,0.12,Ki,Displacement of [3H]ketanserin from human 5HT2A receptor expressed in human A549 cells,Confirmatory,18468904.0,
668,408465,8,5,,103165719,5202,Active,543727.0,3356.0,0.16,Ki,Displacement of [3H]INBMeO from human 5HT2A receptor expressed in human A549 cells,Confirmatory,18468904.0,
669,408466,8,5,,103165719,5202,Active,543727.0,3356.0,0.13,Ki,Displacement of [3H]ketanserin from human 5HT2A receptor expressed in human HEK293 cells,Confirmatory,18468904.0,
670,408467,8,5,,103165719,5202,Active,543727.0,3356.0,0.15,Ki,Displacement of [3H]INBMeO from human 5HT2A receptor expressed in human HEK293 cells,Confirmatory,18468904.0,
671,409958,3,9,,103165719,5202,Inactive,124028637.0,281293.0,,,Inhibition of bovine brain MAOA,Other,18834112.0,
672,409984,7,1,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped-flow CO2 hydrase assay,Other,18930395.0,
673,409986,7,1,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 by stopped-flow CO2 hydrase assay,Other,18930395.0,
674,409988,7,1,,103165719,5202,Unspecified,,,,,Activation of Methanobacterium thermoautotrophicum beta-class CA by stopped-flow CO2 hydrase assay,Other,18930395.0,
675,409990,7,1,,103165719,5202,Active,,,,,Activation of Methanosarcina thermophila Zinc(2)-derived gamma-class CA by stopped-flow CO2 hydrase assay,Other,18930395.0,
676,409992,7,1,,103165719,5202,Active,,,,,Activation of Methanosarcina thermophila cobalt(2)-derived gamma-class CA by stopped-flow CO2 hydrase assay,Other,18930395.0,
677,409993,7,1,,103165719,5202,Active,134047703.0,761.0,,,Activation of human recombinant CA3 by stopped-flow CO2 hydrase assay,Other,18930395.0,
678,414329,7,1,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 by stopped-flow CO2 hydrase method,Other,19231177.0,
679,414330,7,1,,103165719,5202,Unspecified,,,,,Activation of Methanothermobacter thermautotrophicus recombinant Cab by stopped-flow CO2 hydrase method,Other,19231177.0,
680,414331,7,1,,103165719,5202,Active,1709238.0,855692.0,,,Activation of yeast recombinant CA by stopped-flow CO2 hydrase method,Other,19231177.0,
681,415371,9,2,,103165719,5202,Active,8488960.0,3363.0,0.015,EC50,Agonist activity at human recombinant 5HT7 receptor expressed in CHOK1 cells assessed as increase in cAMP levels by HTRF assay,Confirmatory,19326916.0,
682,415572,8,5,,103165719,5202,Active,12644029.0,3360.0,1.0490000000000002,Ki,Displacement of [3H]GR-113808 from human 5HT4 isoform E receptor expressed in rat C6 cells by liquid scintillation counting,Confirmatory,19334715.0,
683,415573,5,6,,103165719,5202,Active,12644029.0,3360.0,0.012,EC50,Agonist activity at human 5HT4 isoform E receptor expressed in rat C6 cells assessed as cAMP accumulation by radio-immunoassay relative to 5HT,Confirmatory,19334715.0,
684,418827,3,10,,103165719,5202,Unspecified,543727.0,3356.0,,,Agonist activity at human 5HT2A receptor expressed in HEK293 cells at 10 uM assessed as calcium flux by FLIPR assay relative to serotonin,Other,19284718.0,
685,418828,9,2,,103165719,5202,Active,543727.0,3356.0,0.0058,EC50,Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay,Confirmatory,19284718.0,
686,418829,9,2,,103165719,5202,Active,1168220.0,3357.0,0.0005,EC50,Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay,Confirmatory,19284718.0,
687,418830,3,10,,103165719,5202,Unspecified,1168220.0,3357.0,,,Agonist activity at human 5HT2B receptor expressed in HEK293 cells at 10 uM assessed as calcium flux by FLIPR assay relative to serotonin,Other,19284718.0,
688,418831,9,2,,103165719,5202,Active,112816.0,3358.0,9e-05,EC50,Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay,Confirmatory,19284718.0,
689,418832,3,10,,103165719,5202,Unspecified,112816.0,3358.0,,,Agonist activity at human 5HT2C receptor expressed in HEK293 cells at 10 uM assessed as calcium flux by FLIPR assay relative to serotonin,Other,19284718.0,
690,418833,3,3,,103165719,5202,Unspecified,,,,,Selectivity ratio of EC50 for human 5HT2A receptor to EC50 for human 5HT2C receptor,Other,19284718.0,
691,418834,3,3,,103165719,5202,Unspecified,,,,,Selectivity ratio of EC50 for human 5HT2B receptor to EC50 for human 5HT2C receptor,Other,19284718.0,
692,426418,3,9,,103165719,5202,Unspecified,12644029.0,3360.0,,,Displacement of [3H]GR-113808 from human 5HT4b receptor expressed in COS7 cell membrane at 100 uM by scintillation counting,Other,19223092.0,
693,426420,8,5,,103165719,5202,Active,12644029.0,3360.0,0.02951,Ki,Displacement of [3H]GR-113808 from human 5HT4b receptor expressed in COS7 cell membrane by scintillation counting,Confirmatory,19223092.0,
694,426421,8,5,,103165719,5202,Active,12644029.0,3360.0,0.10965,Ki,Displacement of [3H]GR-113808 from human recombinant 5HT4b receptor expressed in HEK293 cells by scintillation counting,Confirmatory,19223092.0,
695,428332,9,5,,103165719,5202,Unspecified,152060989.0,22173.0,550.0,IC50,Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation,Confirmatory,19524439.0,
696,428333,3,10,,103165719,5202,Unspecified,152060989.0,22173.0,,,Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation at 100 uM,Other,19524439.0,
697,428334,3,9,,103165719,5202,Unspecified,401235.0,7299.0,,,Inhibition of catecholase activity of tyrosinase in human HMVII cells assessed as dopachrome formation at 100 uM,Other,19524439.0,
698,428335,6,2,,103165719,5202,Unspecified,,,30.0,IC50,Antimelanogenic activity in mouse B16 cells assessed as inhibition of intracellular melanin accumulation after 2 days,Confirmatory,19524439.0,
699,428336,3,4,,103165719,5202,Unspecified,,,,,Cytotoxicity against mouse B16 cells assessed as cell viability at 20 uM after 2 days by tetrazolium reduction assay,Other,19524439.0,
700,431578,7,6,,103165719,5202,Active,112809.0,15561.0,3.4,EC50,Agonist activity at wild type mouse 5HT3A receptor expressed in Xenopus oocyte by two-electrode voltage patch clamp method,Confirmatory,19640719.0,
701,431579,3,3,,103165719,5202,Inconclusive,,,,,Agonist activity at mouse 5HT3A T179A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch clamp method,Other,19640719.0,
702,431580,6,2,,103165719,5202,Unspecified,,,210.0,EC50,Agonist activity at mouse 5HT3A Y143F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
703,431581,3,3,,103165719,5202,Inconclusive,,,,,Agonist activity at mouse 5HT3A Y143A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Other,19640719.0,
704,431582,6,2,,103165719,5202,Active,,,4.4,EC50,Agonist activity at mouse 5HT3A I190V receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
705,431583,3,3,,103165719,5202,Inconclusive,,,,,Agonist activity at mouse 5HT3A I190A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Other,19640719.0,
706,431584,3,3,,103165719,5202,Inconclusive,,,,,Agonist activity at mouse 5HT3A D189A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Other,19640719.0,
707,431585,6,2,,103165719,5202,Active,,,4.4,EC50,Agonist activity at mouse 5HT3A Q188A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
708,431586,6,2,,103165719,5202,Unspecified,,,90.0,EC50,Agonist activity at mouse 5HT3A I187A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
709,431587,6,2,,103165719,5202,Active,,,9.6,EC50,Agonist activity at mouse 5HT3A T186A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
710,431588,6,2,,103165719,5202,Active,,,17.2,EC50,Agonist activity at mouse 5HT3A H185Y receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
711,431589,6,2,,103165719,5202,Active,,,20.9,EC50,Agonist activity at mouse 5HT3A H185F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
712,431590,3,3,,103165719,5202,Inconclusive,,,,,Agonist activity at mouse 5HT3A H185A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Other,19640719.0,
713,431591,6,2,,103165719,5202,Active,,,37.0,EC50,Agonist activity at mouse 5HT3A L184V receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
714,431592,3,3,,103165719,5202,Inconclusive,,,,,Agonist activity at mouse 5HT3A L184A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Other,19640719.0,
715,431593,6,2,,103165719,5202,Unspecified,,,170.0,EC50,Agonist activity at mouse 5HT3A W183F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
716,431594,6,2,,103165719,5202,Active,,,3.3,EC50,Agonist activity at mouse 5HT3A S182A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
717,431595,6,2,,103165719,5202,Active,,,24.0,EC50,Agonist activity at mouse 5HT3A T181A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
718,431596,3,3,,103165719,5202,Inconclusive,,,,,Agonist activity at mouse 5HT3A F180A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Other,19640719.0,
719,431597,6,2,,103165719,5202,Unspecified,,,140.0,EC50,Agonist activity at mouse 5HT3A Y153A receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
720,431598,6,2,,103165719,5202,Active,,,49.0,EC50,Agonist activity at mouse 5HT3A Y153F receptor mutant expressed in Xenopus oocyte by two-electrode voltage patch method,Confirmatory,19640719.0,
721,431599,6,2,,103165719,5202,Active,,,7.1,EC50,Selectivity ratio of EC50 for mouse 5HT3A T181A receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
722,431600,6,2,,103165719,5202,Active,,,0.98,EC50,Selectivity ratio of EC50 for mouse 5HT3A S182A receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
723,431601,6,2,,103165719,5202,Unspecified,,,51.0,EC50,Selectivity ratio of EC50 for mouse 5HT3A W183F receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
724,431602,6,2,,103165719,5202,Active,,,11.0,EC50,Selectivity ratio of EC50 for mouse 5HT3A L184V receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
725,431603,6,2,,103165719,5202,Active,,,6.2,EC50,Selectivity ratio of EC50 for mouse 5HT3A H185F receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
726,431604,6,2,,103165719,5202,Active,,,5.1,EC50,Selectivity ratio of EC50 for mouse 5HT3A H185Y receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
727,431605,6,2,,103165719,5202,Active,,,2.9,EC50,Selectivity ratio of EC50 for mouse 5HT3A T186A receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
728,431606,6,2,,103165719,5202,Active,,,27.0,EC50,Selectivity ratio of EC50 for mouse 5HT3A I187A receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
729,431607,6,2,,103165719,5202,Active,,,1.3,EC50,Selectivity ratio of EC50 for mouse 5HT3A Q188A receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
730,431608,6,2,,103165719,5202,Active,,,1.32,EC50,Selectivity ratio of EC50 for mouse 5HT3A I190V receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
731,431609,6,2,,103165719,5202,Unspecified,,,63.0,EC50,Selectivity ratio of EC50 for mouse 5HT3A Y143F receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
732,431610,6,2,,103165719,5202,Active,,,42.0,EC50,Selectivity ratio of EC50 for mouse 5HT3A Y153A receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
733,431611,6,2,,103165719,5202,Active,,,15.0,EC50,Selectivity ratio of EC50 for mouse 5HT3A Y153F receptor mutant to EC50 for wild type mouse 5HT3A receptor,Confirmatory,19640719.0,
734,436916,7,1,,103165719,5202,Active,,,0.15,EC50,Agonist activity at 5HT1A receptor expressed in CHO cells by [35S]GTPgammaS binding assay,Confirmatory,19559623.0,
735,441264,7,5,,103165719,5202,Active,112812.0,24473.0,0.0016,Ki,Displacement of [3H]8-OHDPAT from 5HT1A receptor in rat hippocampus,Confirmatory,19831400.0,
736,441265,7,5,,103165719,5202,Active,112808.0,29595.0,1.258,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in rat cortex,Confirmatory,19831400.0,
737,441266,7,5,,103165719,5202,Active,6224984.0,100135548.0,0.1,Ki,Displacement of [3H]GR-113808 from 5HT4 receptor in guinea pig striatum,Confirmatory,19831400.0,
738,448097,4,6,,103165719,5202,Active,112816.0,3358.0,0.025,EC50,Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay,Confirmatory,19646865.0,
739,448098,3,10,,103165719,5202,Unspecified,112816.0,3358.0,,,Agonist activity at human recombinant 5HT2C receptor expressed in CHO K1 cells assessed as induction of calcium mobilization by FLIPR assay relative to 5-HT,Other,19646865.0,
740,448099,4,6,,103165719,5202,Active,1168220.0,3357.0,0.011000000000000001,EC50,Agonist activity at human recombinant 5HT2B receptor assessed as induction of calcium mobilization by FLIPR assay,Confirmatory,19646865.0,
741,448100,3,9,,103165719,5202,Unspecified,1168220.0,3357.0,,,Agonist activity at human recombinant 5HT2B receptor assessed as induction of calcium mobilization by FLIPR assay relative to 5-HT,Other,19646865.0,
742,448102,7,1,,103165719,5202,Inconclusive,,,,,Apparent membrane permeability across apical to basolateral side of MDR1 expressing MDCK cells,Other,19646865.0,
743,448103,6,4,,103165719,5202,Inconclusive,,,,,Metabolic stability in human liver microsomes assessed per mg of protein,Other,19646865.0,
744,448113,3,4,,103165719,5202,Inconclusive,,,,,"Lipophilicity, log D at pH 7.4",Other,19646865.0,
745,448115,3,4,,103165719,5202,Inconclusive,,,,,Ratio of apparent permeability from apical to basolateral over basolateral to apical side of MDR1 expressing in MDCK cells,Other,19646865.0,
746,456549,3,8,,103165719,5202,Unspecified,,,,,Inhibition of SERT PDSP analysis,Other,19962901.0,
747,458784,3,10,,103165719,5202,Active,74656605.0,3636621.0,,,Activation of Candida albicans beta-carbonic anhydrase Nce103 by stopped flow CO2 hydration assay,Other,20061162.0,
748,458787,3,3,,103165719,5202,Active,,,,,Activation of Cryptococcus neoformans beta-carbonic anhydrase Can2 by stopped flow CO2 hydration assay,Other,20061162.0,
749,459341,7,5,,103165719,5202,Active,1703010.0,3362.0,0.0275,IC50,Displacement of [3H]LSD from human 5HT6 receptor by scintillation counting,Confirmatory,20170099.0,
750,460128,3,7,,103165719,5202,Unspecified,,,,,Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding relative to control,Other,20041669.0,
751,460129,7,1,,103165719,5202,Active,,,0.147,EC50,Agonist activity at 5HT1A receptor expressed in CHO cells assessed as stimulation of [35S]GTPgamma binding,Confirmatory,20041669.0,
752,460130,3,7,,103165719,5202,Inactive,,,,,Antagonist activity at 5HT1A receptor expressed in CHO cells assessed as inhibition of 5-HT-stimulated [35S]GTPgamma binding relative to control,Other,20041669.0,
753,460131,7,1,,103165719,5202,Inactive,,,,IC50,Agonist activity at 5HT1A receptor expressed in CHO cells assessed as inhibition of 5-HT-stimulated [35S]GTPgamma binding,Confirmatory,20041669.0,
754,462829,3,9,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped flow CO2 hydration assay,Other,20176489.0,
755,462830,3,9,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2by stopped flow CO2 hydration assay,Other,20176489.0,
756,462831,3,9,,103165719,5202,Active,116241278.0,765.0,,,Activation of human full length CA6 by stopped flow CO2 hydration assay,Other,20176489.0,
757,462832,3,3,,103165719,5202,Unspecified,,,,,Activation of Stylophora pistillata carbonic anhydrase STPCA by stopped flow CO2 hydration assay,Other,20176489.0,
758,463106,1,2,,90341122,5202,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
759,464319,3,9,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant carbonic anhydrase isoenzyme 2 by stopped flow CO2 hydration method,Other,20129782.0,
760,464320,3,7,,103165719,5202,Unspecified,,,,,Activation of archaea Methanobacterium thermoautotrophicum recombinant carbonic anhydrase by stopped flow CO2 hydration method,Other,20129782.0,
761,464321,3,9,,103165719,5202,Active,1709238.0,855692.0,,,Activation of Saccharomyces cerevisiae recombinant Nce103p by stopped flow CO2 hydration method,Other,20129782.0,
762,464322,3,9,,103165719,5202,Active,74610182.0,,,,Activation of Candida glabrata recombinant carbonic anhydrase by stopped flow CO2 hydration method,Other,20129782.0,
763,480937,10,1,,103165719,5202,Active,,,0.05,Ki,Displacement of [3H]8-OH-DPAT from 5HT1A receptor expressed in HEK293 cells after 2 hrs by liquid scintillation counting,Confirmatory,20363635.0,
764,480939,3,6,,103165719,5202,Unspecified,,,,,Agonist activity at 5HT1A receptor expressed in HEK293 cells by [S35]GTPgammaS binding assay relative to 8-OH-DPAT,Other,20363635.0,
765,485281,1,1,,11111289,5202,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
766,485290,1,1,,11111289,5202,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
767,485290,1,1,,26754231,5202,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
768,485290,1,1,,26754232,5202,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
769,485290,1,1,,26754233,5202,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
770,485295,1,2,,90341122,5202,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
771,485297,1,1,,90341122,5202,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
772,485298,1,1,,90341122,5202,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
773,485313,1,2,,90341122,5202,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
774,485342,1,2,,90341122,5202,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
775,485345,1,2,,90341122,5202,Inactive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
776,485350,1,2,,99301004,5202,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
777,485366,1,2,,90341122,5202,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
778,485368,1,2,,90341122,5202,Inactive,72386991.0,3656265.0,,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
779,488772,1,1,,90341122,5202,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
780,488773,1,2,,90341122,5202,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
781,488816,1,1,,90341122,5202,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
782,488837,1,1,,90341122,5202,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
783,488949,1,2,,90341122,5202,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
784,488953,1,1,,90341122,5202,Inactive,187960037.0,10951.0,,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
785,488978,1,1,,90341122,5202,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
786,488981,1,1,,90341122,5202,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
787,488982,1,1,,90341122,5202,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
788,488983,1,1,,90341122,5202,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
789,493033,1,2,,99301004,5202,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
790,493106,1,1,,90341122,5202,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
791,493107,1,1,,90341122,5202,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
792,493153,1,1,,90341122,5202,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
793,493153,1,1,,90341122,5202,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
794,493162,1,2,,99302524,5202,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
795,493164,1,2,,90341122,5202,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
796,493164,1,2,,90341122,5202,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
797,493164,1,2,,90341122,5202,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
798,504327,1,1,,11111289,5202,Active,153791535.0,2648.0,11.2202,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
799,504327,1,1,,90341122,5202,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
800,504332,1,1,,11111289,5202,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
801,504332,1,1,,90341122,5202,Active,168985070.0,,21.1923,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
802,504536,1,1,,90341122,5202,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
803,504547,1,1,,90341122,5202,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
804,504548,1,2,,90341122,5202,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
805,504810,1,2,,90341122,5202,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
806,504812,1,2,,90341122,5202,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
807,504836,1,2,,90341122,5202,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
808,504845,1,1,,90341122,5202,Inconclusive,86301163.0,5999.0,4.7398,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
809,504847,1,1,,11111289,5202,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
810,504847,1,1,,90341122,5202,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
811,504865,1,1,,11111289,5202,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
812,504865,1,1,,90341122,5202,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
813,538752,3,9,,103165719,5202,Inactive,143811469.0,79054.0,,,Antagonist activity at human TRPM8 receptor expressed in HEK cells assessed as inhibition of WS-12-stimulated current at 100 uM pretreated for 2 mins by patch clamp assay,Other,20965726.0,
814,539554,11,2,,103165719,5202,Unspecified,13123962.0,,301.0,IC50,Inhibition of Candida albicans isocitrate lyase,Confirmatory,21035332.0,
815,539555,10,2,,103165719,5202,Unspecified,75421586.0,,,IC50,Inhibition of Staphylococcus aureus Sortase A,Confirmatory,21035332.0,
816,540256,1,2,,90341122,5202,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
817,540276,1,2,,11111288,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
818,540276,1,2,,11111289,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
819,540276,1,2,,26754231,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
820,540276,1,2,,26754232,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
821,540276,1,2,,26754233,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
822,540276,1,2,,50109811,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
823,540276,1,2,,50109812,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
824,540276,1,2,,90341122,5202,Inconclusive,420597.0,,4.609,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
825,540299,1,2,,99302524,5202,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
826,552107,3,6,,103165719,5202,Active,1168222.0,3359.0,0.17800000000000002,EC50,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response,Confirmatory,21146988.0,
827,552111,3,6,,103165719,5202,Active,1168222.0,3359.0,0.141,EC50,Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release,Confirmatory,21146988.0,
828,566271,2,4,,103165719,5202,Active,,,0.0027,IC50,Inhibition of rat 5-HT receptor,Confirmatory,20875743.0,
829,588346,1,1,,124880368,5202,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a: Hit Confirmation in b-rIgG Counterscreen,Confirmatory,,
830,588349,1,1,,90341122,5202,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
831,588378,1,1,,90341122,5202,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
832,588379,1,2,,124880363,5202,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
833,588453,1,1,,90341122,5202,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
834,588453,1,1,,124880368,5202,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
835,588456,1,1,,90341122,5202,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
836,588456,1,1,,124880368,5202,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
837,588519,1,2,,99301004,5202,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
838,588519,1,2,,99302524,5202,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
839,588579,1,1,,11111289,5202,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
840,588579,1,1,,90341122,5202,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
841,588579,1,1,,124880363,5202,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
842,588579,1,1,,124880365,5202,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
843,588579,1,1,,124880366,5202,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
844,588579,1,1,,124880368,5202,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
845,588590,1,1,,124880368,5202,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
846,588795,1,1,,90341122,5202,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
847,588795,1,1,,124880368,5202,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
848,589071,1,10,,103165719,5202,Unspecified,29840832.0,54578.0,,,Substrate of human UDP-glucuronosyltransferase UGT1A6,Other,,
849,590194,3,3,,103165719,5202,Unspecified,,,250.0,EC50,Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry,Confirmatory,21377874.0,
850,590195,6,5,,103165719,5202,Unspecified,6686057.0,,350.0,IC50,Inhibition of mushroom tyrosinase after 25 mins by spectrophotometry,Confirmatory,21377874.0,
851,602314,1,2,,99301004,5202,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
852,602332,1,1,,11111289,5202,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
853,602332,1,1,,90341122,5202,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
854,602332,1,1,,124880363,5202,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
855,602332,1,1,,124880365,5202,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
856,602332,1,1,,124880366,5202,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
857,611933,4,5,,103165719,5202,Active,112821.0,3351.0,0.013999999999999999,Ki,Displacement of [125I]CYP from human 5HT1B receptor,Confirmatory,21726069.0,
858,611937,4,5,,103165719,5202,Active,1345607.0,3361.0,0.17,Ki,Displacement of [3H]LSD from human 5HT5A receptor,Confirmatory,21726069.0,
859,611938,4,5,,103165719,5202,Active,1703010.0,3362.0,0.084,Ki,Displacement of [3H]LSD from human 5HT6 receptor,Confirmatory,21726069.0,
860,611939,4,5,,103165719,5202,Active,8488960.0,3363.0,0.00013000000000000002,Ki,Displacement of [3H]LSD from human 5HT7 receptor,Confirmatory,21726069.0,
861,620966,5,5,,103165719,5202,Active,112812.0,24473.0,0.0026,Ki,Displacement of [3H]8OH-DPAT from 5HT1A in rat brain cerebral cortex after 15 mins by scintillation counting,Confirmatory,21816515.0,
862,624146,1,1,,90341122,5202,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
863,624147,1,1,,90341122,5202,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
864,624148,1,2,,90341122,5202,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
865,624149,1,1,,90341122,5202,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
866,624178,1,1,,124880368,5202,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
867,624184,1,1,,135651413,5202,Active,113865998.0,15566.0,,,Agonists at Mouse 5-Hydroxytryptamine receptor 5-HT7,Other,8394987.0,
868,624185,1,1,,135651413,5202,Active,12621102.0,65032.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT7,Other,8394362.0,
869,624185,1,1,,135651413,5202,Active,12621102.0,65032.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT7,Other,8397408.0,
870,624187,1,1,,135651413,5202,Active,10880131.0,3363.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT7,Other,8226867.0,
871,624187,1,1,,135651413,5202,Active,10880131.0,3363.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT7,Other,9298538.0,
872,624187,1,1,,135651413,5202,Active,10880131.0,3363.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT7,Other,9720804.0,
873,624187,1,1,,135651413,5202,Active,10880131.0,3363.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT7,Other,11414657.0,
874,624187,1,1,,135651413,5202,Active,10880131.0,3363.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT7,Other,12527336.0,
875,624188,1,1,,135651413,5202,Active,6981062.0,25689.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-ht5a,Other,7682702.0,
876,624189,1,1,,135651413,5202,Active,13242259.0,64354.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT6,Other,7680751.0,
877,624189,1,1,,135651413,5202,Active,13242259.0,64354.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT6,Other,9225298.0,
878,624189,1,1,,135651413,5202,Active,13242259.0,64354.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT6,Other,9730917.0,
879,624189,1,1,,135651413,5202,Active,13242259.0,64354.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT6,Other,9798944.0,
880,624191,1,1,,135651413,5202,Active,4504545.0,3362.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT6,Other,8522988.0,
881,624191,1,1,,135651413,5202,Active,4504545.0,3362.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT6,Other,9284367.0,
882,624191,1,1,,135651413,5202,Active,4504545.0,3362.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT6,Other,9730917.0,
883,624193,1,1,,135651413,5202,Active,84370345.0,15563.0,,,Agonists at Mouse 5-Hydroxytryptamine receptor 5-ht5a,Other,8450829.0,
884,624193,1,1,,135651413,5202,Active,84370345.0,15563.0,,,Agonists at Mouse 5-Hydroxytryptamine receptor 5-ht5a,Other,8549774.0,
885,624193,1,1,,135651413,5202,Active,84370345.0,15563.0,,,Agonists at Mouse 5-Hydroxytryptamine receptor 5-ht5a,Other,11343685.0,
886,624199,1,1,,135651413,5202,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,1565658.0,
887,624199,1,1,,135651413,5202,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,1652050.0,
888,624199,1,1,,135651413,5202,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,8957260.0,
889,624199,1,1,,135651413,5202,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,8967979.0,
890,624199,1,1,,135651413,5202,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,9208142.0,
891,624199,1,1,,135651413,5202,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,9776361.0,
892,624199,1,1,,135651413,5202,Active,4504535.0,3352.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1D,Other,10431754.0,
893,624202,1,1,,124880368,5202,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
894,624210,1,1,,135651413,5202,Active,55956923.0,3350.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A,Other,1386736.0,
895,624210,1,1,,135651413,5202,Active,55956923.0,3350.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A,Other,9205951.0,
896,624210,1,1,,135651413,5202,Active,55956923.0,3350.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A,Other,9550290.0,
897,624210,1,1,,135651413,5202,Active,55956923.0,3350.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A,Other,9760039.0,
898,624210,1,1,,135651413,5202,Active,55956923.0,3350.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A,Other,10431754.0,
899,624210,1,1,,135651413,5202,Active,55956923.0,3350.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1A,Other,15628665.0,
900,624211,1,1,,135651413,5202,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,1565658.0,
901,624211,1,1,,135651413,5202,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,8863519.0,
902,624211,1,1,,135651413,5202,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,8957260.0,
903,624211,1,1,,135651413,5202,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,9208142.0,
904,624211,1,1,,135651413,5202,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,9776361.0,
905,624211,1,1,,135651413,5202,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,10431754.0,
906,624211,1,1,,135651413,5202,Active,4504533.0,3351.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1B,Other,11040052.0,
907,624212,1,1,,135651413,5202,Active,13236497.0,3361.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-ht5a,Other,7988681.0,
908,624212,1,1,,135651413,5202,Active,13236497.0,3361.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-ht5a,Other,11343685.0,
909,624214,1,1,,135651413,5202,Active,17298688.0,25187.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT2C,Other,9282936.0,
910,624214,1,1,,135651413,5202,Active,17298688.0,25187.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT2C,Other,11104741.0,
911,624216,2,1,,135651413,5202,Active,377520139.0,3358.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2C,Other,10217294.0,
912,624216,2,1,,135651413,5202,Active,377520139.0,3358.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2C,Other,10611640.0,
913,624216,2,1,,135651413,5202,Active,377520139.0,3358.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2C,Other,12954071.0,
914,624216,2,1,,135651413,5202,Active,377520139.0,3358.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2C,Other,14709324.0,
915,624216,2,1,,135651413,5202,Active,377520139.0,3358.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2C,Other,15322733.0,
916,624219,2,1,,135651413,5202,Active,222080049.0,3357.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2B,Other,8078486.0,
917,624219,2,1,,135651413,5202,Active,222080049.0,3357.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2B,Other,11104741.0,
918,624219,2,1,,135651413,5202,Active,222080049.0,3357.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2B,Other,12954071.0,
919,624219,2,1,,135651413,5202,Active,222080049.0,3357.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2B,Other,15322733.0,
920,624219,2,1,,135651413,5202,Active,222080049.0,3357.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2B,Other,15466450.0,
921,624220,1,1,,135651413,5202,Active,6754258.0,15551.0,,,Agonists at Mouse 5-Hydroxytryptamine receptor 5-HT1B,Other,1557407.0,
922,624227,1,1,,135651413,5202,Active,281599319.0,60448.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT1F,Other,8384716.0,
923,624230,1,1,,135651413,5202,Active,4504537.0,3354.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-ht1e,Other,1608964.0,
924,624230,1,1,,135651413,5202,Active,4504537.0,3354.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-ht1e,Other,8380639.0,
925,624230,1,1,,135651413,5202,Active,4504537.0,3354.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-ht1e,Other,14744596.0,
926,624230,1,1,,135651413,5202,Active,4504537.0,3354.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-ht1e,Other,15110837.0,
927,624233,1,1,,135651413,5202,Active,10835197.0,3355.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1F,Other,8380639.0,
928,624233,1,1,,135651413,5202,Active,10835197.0,3355.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1F,Other,9225282.0,
929,624233,1,1,,135651413,5202,Active,10835197.0,3355.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT1F,Other,15900510.0,
930,624234,1,1,,135651413,5202,Active,8393583.0,29595.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT2A,Other,9655845.0,
931,624234,1,1,,135651413,5202,Active,8393583.0,29595.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT2A,Other,11040033.0,
932,624234,1,1,,135651413,5202,Active,8393583.0,29595.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT2A,Other,11104741.0,
933,624235,2,1,,135651413,5202,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,2233697.0,
934,624235,2,1,,135651413,5202,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,8114677.0,
935,624235,2,1,,135651413,5202,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,8534270.0,
936,624235,2,1,,135651413,5202,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,8663249.0,
937,624235,2,1,,135651413,5202,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,12954071.0,
938,624235,2,1,,135651413,5202,Active,260099679.0,3356.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT2A,Other,15322733.0,
939,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,9349523.0,
940,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,9351641.0,
941,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,9603189.0,
942,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,10646498.0,
943,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,10683202.0,
944,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,10821780.0,
945,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,11030734.0,
946,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,11218067.0,
947,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,15351779.0,
948,624236,1,1,,135651413,5202,Active,297206833.0,3360.0,,,Agonists at Human 5-Hydroxytryptamine receptor 5-HT4,Other,15466450.0,
949,624237,1,1,,135651413,5202,Active,84370240.0,15562.0,,,Agonists at Mouse 5-Hydroxytryptamine receptor 5-HT4,Other,8946946.0,
950,624239,1,1,,135651413,5202,Active,6981060.0,25324.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT4,Other,7796807.0,
951,624239,1,1,,135651413,5202,Active,6981060.0,25324.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT4,Other,8813606.0,
952,624239,1,1,,135651413,5202,Active,6981060.0,25324.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT4,Other,9225293.0,
953,624240,1,1,,135651413,5202,Active,8393586.0,29581.0,,,Agonists at Rat 5-Hydroxytryptamine receptor 5-HT2B,Other,8450835.0,
954,624263,1,1,,124880368,5202,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
955,624263,1,1,,124880368,5202,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
956,624414,1,1,,124880368,5202,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
957,624455,1,1,,90341122,5202,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
958,624606,1,9,,103165719,5202,Unspecified,136729.0,54658.0,,,Specific activity of expressed human recombinant UGT1A1,Other,10836148.0,
959,624608,3,2,,103165719,5202,Unspecified,136731.0,54657.0,,,Specific activity of expressed human recombinant UGT1A4,Other,10836148.0,
960,624616,1,8,,103165719,5202,Unspecified,332278237.0,7366.0,,,Specific activity of expressed human recombinant UGT2B15,Other,10836148.0,
961,624617,1,8,,103165719,5202,Unspecified,6136104.0,7367.0,,,Specific activity of expressed human recombinant UGT2B17,Other,10836148.0,
962,624618,3,2,,103165719,5202,Unspecified,6175083.0,7363.0,,,Specific activity of expressed human recombinant UGT2B4,Other,10836148.0,
963,624619,3,2,,103165719,5202,Unspecified,136727.0,7364.0,,,Specific activity of expressed human recombinant UGT2B7,Other,10836148.0,
964,651635,1,3,,11111289,5202,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
965,651635,1,3,,90341122,5202,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
966,651965,1,1,,124880368,5202,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
967,652106,1,1,,90341122,5202,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
968,652106,1,1,,124880368,5202,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
969,652616,1,5,,103165719,5202,Unspecified,,,,,Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes at 10 uM after 90 mins by scintillation counting,Other,22381048.0,
970,652617,1,5,,103165719,5202,Unspecified,,,,,Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes at 1 uM after 90 mins by scintillation counting,Other,22381048.0,
971,652618,3,2,,103165719,5202,Active,,,0.214,Ki,Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes after 90 mins by scintillation counting,Confirmatory,22381048.0,
972,652619,1,4,,103165719,5202,Active,,,0.0016300000000000002,EC50,Agonist activity at 5HT2C receptor expressed in CHO cells by fluorescence based calcium mobilization assay,Confirmatory,22381048.0,
973,652620,3,2,,103165719,5202,Active,,,0.445,Ki,Displacement of [3H]-mesulergine from 5HT2C receptor expressed in CHO cell membranes using 11 concentration of ligand after 90 mins by scintillation counting using complete competition binding curves analysis,Confirmatory,22381048.0,
974,652654,4,2,,103165719,5202,Unspecified,,,400.0,IC50,Inhibition of COX1 after 5 mins by spectrophotometric analysis,Confirmatory,22386242.0,
975,652655,4,2,,103165719,5202,Unspecified,,,400.0,IC50,Inhibition of COX2 after 5 mins by spectrophotometric analysis,Confirmatory,22386242.0,
976,656681,1,8,,103165719,5202,Unspecified,14916521.0,,,,Inhibition of electric eel AChE using acetylcholine iodide as substrate at 10'-4 M measured every 5 sec for 2 mins by Ellman's method,Other,22425563.0,
977,656684,5,5,,103165719,5202,Inconclusive,113037.0,43.0,,IC50,Inhibition of human AChE by Ellman's method,Confirmatory,22425563.0,
978,656685,1,8,,103165719,5202,Unspecified,113037.0,43.0,,,Inhibition of human AChE at 10'-4 M by Ellman's method,Other,22425563.0,
979,658524,2,6,,103165719,5202,Active,543727.0,3356.0,0.0076,EC50,Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay,Confirmatory,22778800.0,
980,658527,2,6,,103165719,5202,Active,1168220.0,3357.0,0.00086,EC50,Agonist activity at human 5HT2B receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay,Confirmatory,22778800.0,
981,658530,2,6,,103165719,5202,Active,112816.0,3358.0,9e-05,EC50,Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as calcium flux measured every sec for 3 mins by FLIPR assay,Confirmatory,22778800.0,
982,672323,4,6,,103165719,5202,Active,6224984.0,100135548.0,0.01,EC50,Agonist activity at 5HT4 receptor in guinea pig colon assessed as longitudinal muscle plexus contraction,Confirmatory,22683222.0,
983,673212,4,5,,103165719,5202,Active,231454.0,3350.0,0.00062,Ki,Displacement of [3H]-8-OH-DPAT from human 5HT1A receptor expressed in HEK293 cells,Confirmatory,22748706.0,
984,678817,2,7,,103165719,5202,Unspecified,81872095.0,24904.0,37.6,Km,TP_TRANSPORTER: uptake (electrogenesis) in Xenopus laevis oocytes,Confirmatory,8898084.0,
985,678842,2,7,,103165719,5202,Unspecified,24212063.0,6581.0,,Km,TP_TRANSPORTER: uptake in OCT3-expressing HEK293 cells,Confirmatory,10196521.0,
986,679157,2,7,,103165719,5202,Unspecified,313104182.0,6582.0,80.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,9687576.0,
987,680530,1,7,,103165719,5202,Unspecified,8928277.0,20520.0,,,"TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.01 uM, Serotonin: 5000 uM) in OCTN2-expressing HEK293 cells",Other,11160873.0,
988,681368,3,6,,103165719,5202,Unspecified,81872789.0,29503.0,242.0,Ki,TP_TRANSPORTER: inhibition of TEA uptake in OCT2-expressing MDCK cells,Confirmatory,11758759.0,
989,681375,3,6,,103165719,5202,Unspecified,81872095.0,24904.0,390.0,Ki,TP_TRANSPORTER: inhibition of TEA uptake in OCT1-expressing MDCK cells,Confirmatory,11758759.0,
990,681565,2,7,,103165719,5202,Unspecified,81872789.0,29503.0,3600.0,Km,TP_TRANSPORTER: uptake in OCT2-expressing HEK293 cells,Confirmatory,9812985.0,
991,681601,1,7,,103165719,5202,Unspecified,81872095.0,24904.0,,,TP_TRANSPORTER: uptake in OCT1-expressing HEK293 cells,Other,9776363.0,
992,681694,1,7,,103165719,5202,Unspecified,8928242.0,29726.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 20 uM, Serotonin: 2500 uM) in OCTN2-expressing HRPE cells",Other,10454528.0,
993,681969,1,7,,103165719,5202,Unspecified,313104182.0,6582.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 5 uM, Serotonin: 1000 uM) in OCT2A-expressing HEK293 cells",Other,12089365.0,
994,681970,1,7,,103165719,5202,Unspecified,313104182.0,6582.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 5 uM, Serotonin: 1000 uM) in OCT2-expressing HEK293 cells",Other,12089365.0,
995,682029,3,6,,103165719,5202,Unspecified,24212062.0,29504.0,97.0,IC50,TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in OCT3-expressing HRPE cells,Confirmatory,9830022.0,
996,682223,1,7,,103165719,5202,Unspecified,24212062.0,29504.0,,,"TP_TRANSPORTER: inhibition of Guanidine uptake (Guanidine: 35 uM, Serotonin: 5000 uM) in OCT3-expressing HeLa cells",Other,9632645.0,
997,686970,1,2,,124880368,5202,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
998,686971,1,2,,124880368,5202,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
999,686977,2,1,,49698514,5202,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1000,686978,1,1,,124880363,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1001,686978,1,1,,124880365,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1002,686978,1,1,,124880366,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1003,686978,1,1,,124880368,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1004,686979,1,1,,124880363,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1005,686979,1,1,,124880365,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1006,686979,1,1,,124880366,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1007,686979,1,1,,124880368,5202,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1008,688847,1,2,,103165719,5202,Unspecified,,,,,"Octanol-phosphate buffered saline partition coefficient, log K of the compound",Other,22047697.0,
1009,691713,1,7,,103165719,5202,Active,115449.0,759.0,,,Activity of human recombinant CA1 cytosolic isoform after 15 mins by phenol red staining based stopped flow CO2 hydration assay,Other,22999416.0,
1010,691714,1,7,,103165719,5202,Unspecified,115456.0,760.0,,,Activity of human recombinant CA2 cytosolic isoform after 15 mins by phenol red staining based stopped flow CO2 hydration assay,Other,22999416.0,
1011,691715,1,2,,103165719,5202,Active,,,,,Activity of Sulfurihydrogenibium yellowstonense YO3AOP1 recombinant CA expressed in Escherichia coli BL21(DE3) after 15 mins by phenol red staining based stopped flow CO2 hydration assay,Other,22999416.0,
1012,720532,1,1,,11111289,5202,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1013,720532,1,1,,124880363,5202,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1014,720532,1,1,,124880365,5202,Inconclusive,420597.0,,39.8107,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1015,720532,1,1,,124880366,5202,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1016,720533,1,1,,11111289,5202,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1017,720533,1,1,,124880363,5202,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1018,720533,1,1,,124880365,5202,Inconclusive,,,35.4813,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1019,720533,1,1,,124880366,5202,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1020,720538,1,2,,90341122,5202,Inactive,220983390.0,410.0,4.2562,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
1021,720559,1,2,,90341122,5202,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
1022,720572,1,2,,90341122,5202,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
1023,720573,1,2,,90341122,5202,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
1024,720579,2,1,,124880365,5202,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1025,720579,2,1,,124880366,5202,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1026,720579,2,1,,124880368,5202,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1027,720580,1,1,,124880365,5202,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1028,720580,1,1,,124880366,5202,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1029,720580,1,1,,124880368,5202,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1030,720717,1,3,,92310092,5202,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1031,723785,1,6,,103165719,5202,Unspecified,231454.0,3350.0,,,Agonist activity at human 5HT1A receptor expressed in HeLa cell membranes by [35S]GTPgammaS binding assay,Other,23252794.0,
1032,725226,1,2,,103165719,5202,Active,,,,,Activation of Sulfurihydrogenibium azorense recombinant alpha carbonic anhydrase by stopped flow CO2 hydrase method,Other,23294703.0,
1033,725227,1,2,,103165719,5202,Active,,,,,Activation of Sulfurihydrogenibium yellowstonense recombinant CA by stopped flow CO2 hydrase method,Other,23294703.0,
1034,725228,1,6,,103165719,5202,Active,115449.0,759.0,,,Activation of human recombinant CA1 by stopped flow CO2 hydrase method,Other,23294703.0,
1035,725229,1,6,,103165719,5202,Unspecified,115456.0,760.0,,,Activation of human recombinant CA2 by stopped flow CO2 hydrase method,Other,23294703.0,
1036,729692,3,1,,103165719,5202,Inconclusive,118206.0,1813.0,,IC50,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,Confirmatory,23332346.0,
1037,729708,5,1,,103165719,5202,Unspecified,231454.0,3350.0,,EC50,Agonist activity at 5-HT1A receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,Confirmatory,23332346.0,
1038,729709,3,1,,103165719,5202,Inconclusive,118228.0,1812.0,,IC50,Antagonist activity at dopamine D1 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,Confirmatory,23332346.0,
1039,729710,3,1,,103165719,5202,Inconclusive,118228.0,1812.0,,EC50,Agonist activity at dopamine D1 receptor (unknown origin) expressed in HEK293 cells assessed as stimulation of [35S]GTPgammaS binding by scintillation proximity assay,Confirmatory,23332346.0,
1040,729711,2,5,,103165719,5202,Inconclusive,543727.0,3356.0,,Ki,Displacement of [3H]Ketanserin from 5-HT2A receptor (unknown origin) expressed in HEK293 cells by liquid scintillation counter,Confirmatory,23332346.0,
1041,729712,2,5,,103165719,5202,Active,231454.0,3350.0,0.0009,Ki,Displacement of [3H]8-OH-DPAT from 5-HT1A receptor (unknown origin) expressed in HEK293 cells by liquid scintillation counter,Confirmatory,23332346.0,
1042,729713,2,5,,103165719,5202,Inconclusive,118206.0,1813.0,,Ki,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,Confirmatory,23332346.0,
1043,729714,2,5,,103165719,5202,Inconclusive,118228.0,1812.0,,Ki,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,Confirmatory,23332346.0,
1044,729715,1,6,,103165719,5202,Inconclusive,543727.0,3356.0,,,Inhibition of [3H]Ketanserin binding to 5-HT2A receptor (unknown origin) expressed in HEK293 cells at 10 uM by liquid scintillation counter relative to control,Other,23332346.0,
1045,729716,1,6,,103165719,5202,Unspecified,231454.0,3350.0,,,Inhibition of [3H]8-OH-DPAT binding to 5-HT1A receptor (unknown origin) expressed in HEK293 cells at 10 uM by liquid scintillation counter relative to control,Other,23332346.0,
1046,729717,1,6,,103165719,5202,Inconclusive,118206.0,1813.0,,,Inhibition of [3H]spiperone binding to dopamine D2 receptor (unknown origin) expressed in human HEK293 cells at 10 uM by liquid scintillation counter relative to control,Other,23332346.0,
1047,729718,1,6,,103165719,5202,Inconclusive,118228.0,1812.0,,,Inhibition of [3H]SCH23390 binding to dopamine D1 receptor (unknown origin) expressed in human HEK293 cells at 10 uM by liquid scintillation counter relative to control,Other,23332346.0,
1048,733541,1,6,,103165719,5202,Inactive,112817.0,25187.0,,,Displacement of [125I]-N-(p-I-Bn)-THAZ from 5HT2C in rat cerebral cortex membrane up to 50 uM after 1 hr by scintillation counting analysis,Other,23301527.0,
1049,733542,1,6,,103165719,5202,Inactive,112817.0,25187.0,,,Displacement of [125I]-N-(p-I-Bn)-THAZ from 5HT2C receptor in rat midbrain membrane after 1 hr by scintillation counting analysis,Other,23301527.0,
1050,733544,1,6,,103165719,5202,Inactive,112817.0,25187.0,,,Displacement of [125I]-N-(p-I-Bn)-THAZ from 5HT2C receptor in rat hippocampal membrane after 1 hr by scintillation counting analysis,Other,23301527.0,
1051,733545,1,6,,103165719,5202,Inactive,112817.0,25187.0,,,Displacement of [125I]-N-(p-I-Bn)-THAZ from 5HT2C receptor in rat cerebellum membrane after 1 hr by scintillation counting analysis,Other,23301527.0,
1052,733546,4,2,,103165719,5202,Active,112816.0,3358.0,0.07943,Ki,Displacement of [3H]mesulergine from human 5HT2C receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis,Confirmatory,23301527.0,
1053,733547,4,2,,103165719,5202,Active,543727.0,3356.0,0.32359,Ki,Displacement of [3H]ketanserin from human 5HT2A receptor expressed in tsA201 cell membranes after 1 hr by scintillation counting analysis,Confirmatory,23301527.0,
1054,733548,4,2,,103165719,5202,Active,543727.0,3356.0,0.14790999999999999,EC50,Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay,Confirmatory,23301527.0,
1055,733549,4,2,,103165719,5202,Active,112816.0,3358.0,0.04365,EC50,Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as accumulation of IP1 incubated for 1 hr at 37 degC followed by 15 mins at RT by TR-FRET assay,Confirmatory,23301527.0,
1056,733559,5,1,,103165719,5202,Active,112816.0,3358.0,0.0008710000000000001,EC50,Agonist activity at human 5HT2C receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay,Confirmatory,23301527.0,
1057,733560,5,1,,103165719,5202,Active,543727.0,3356.0,0.00257,EC50,Agonist activity at human 5HT2A receptor expressed in HEK293 cells assessed as induction of intracellular calcium release measured for 90 secs by fluorescence assay,Confirmatory,23301527.0,
1058,738129,2,5,,103165719,5202,Inactive,129825.0,4353.0,,IC50,Inhibition of human recombinant MPO-mediated taurine chlorination after 5 mins by microplate assay,Confirmatory,23581551.0,
1059,743205,1,1,,90341122,5202,Inactive,4503951.0,2645.0,2.8184,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1060,743205,1,1,,90341122,5202,Inactive,221625433.0,2646.0,2.8184,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1061,743206,1,1,,90341122,5202,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1062,743206,1,1,,90341122,5202,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1063,743207,1,1,,90341122,5202,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1064,743207,1,1,,90341122,5202,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1065,743244,1,1,,90341122,5202,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1066,744698,2,3,,103165719,5202,Inconclusive,400629.0,25553.0,,Ki,Displacement of [3H]-citalopram from SERT in rat cerebral cortex after 1 hr by liquid scintillation counting analysis,Confirmatory,23524160.0,
1067,744699,2,3,,103165719,5202,Active,112812.0,24473.0,0.0021,Ki,Displacement of [3H]-8-OH-DPAT from 5HT1A receptor in rat hippocampal membranes after 20 mins,Confirmatory,23524160.0,
1068,750631,2,3,,103165719,5202,Active,543727.0,3356.0,0.016,EC50,Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay,Confirmatory,23675993.0,
1069,750633,1,5,,103165719,5202,Unspecified,543727.0,3356.0,,,Agonist activity at 5HT2A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 at 10 uM by FLIPR assay relative to control,Other,23675993.0,
1070,750636,2,3,,103165719,5202,Active,231454.0,3350.0,0.039,EC50,Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 by FLIPR assay,Confirmatory,23675993.0,
1071,750637,1,5,,103165719,5202,Unspecified,231454.0,3350.0,,,Agonist activity at 5HT1A receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 at 10 uM by FLIPR assay relative to control,Other,23675993.0,
1072,751846,2,3,,103165719,5202,Active,8488960.0,3363.0,,IC50,Binding affinity to human 5-HT7 receptor by radioligand displacement assay,Confirmatory,23466604.0,
1073,751848,2,3,,103165719,5202,Active,1703010.0,3362.0,,IC50,Binding affinity to human 5-HT6 receptor by radioligand displacement assay,Confirmatory,23466604.0,
1074,751849,2,3,,103165719,5202,Active,1345607.0,3361.0,,IC50,Binding affinity to human 5-HT5a receptor by radioligand displacement assay,Confirmatory,23466604.0,
1075,751853,2,3,,103165719,5202,Active,112821.0,3351.0,,IC50,Binding affinity to human 5-HT1B receptor by radioligand displacement assay,Confirmatory,23466604.0,
1076,752210,2,3,,103165719,5202,Active,8488960.0,3363.0,0.00049,IC50,Binding affinity to human 5-HT7 receptor by radioligand displacement assay,Confirmatory,23582449.0,
1077,752211,2,3,,103165719,5202,Active,1703010.0,3362.0,0.18,IC50,Binding affinity to human 5-HT6 receptor by radioligand displacement assay,Confirmatory,23582449.0,
1078,752212,2,3,,103165719,5202,Active,1345607.0,3361.0,0.28,IC50,Binding affinity to human 5-HT5A receptor by radioligand displacement assay,Confirmatory,23582449.0,
1079,752217,2,3,,103165719,5202,Active,112821.0,3351.0,0.012,IC50,Binding affinity to 5-HT1B receptor (unknown origin) by radioligand displacement assay,Confirmatory,23582449.0,
1080,752429,5,1,,103165719,5202,Active,112816.0,3358.0,0.0004,EC50,Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay,Confirmatory,23602445.0,
1081,752431,4,2,,103165719,5202,Active,1168220.0,3357.0,0.0011,EC50,Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay,Confirmatory,23602445.0,
1082,752433,5,1,,103165719,5202,Active,543727.0,3356.0,0.0015,EC50,Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as increase in calcium mobilization by FLIPR assay,Confirmatory,23602445.0,
1083,763642,1,5,,103165719,5202,Inactive,112812.0,24473.0,,,Displacement of [3H]-8-OH-DPAT from 5HT1A receptor in rat brain hippocampal membranes after 15 mins by competition assay,Other,23792350.0,
1084,763648,2,3,,103165719,5202,Active,112808.0,29595.0,13.0,IC50,Displacement of [3H]-ketanserin from 5HT2A receptor in rat brain cortical membranes after 15 mins by competition assay in presence of Gpp(NH)p,Confirmatory,23792350.0,
1085,763649,2,3,,103165719,5202,Active,112808.0,29595.0,30.6,IC50,Displacement of [3H]-ketanserin from 5HT2A receptor low affinity component in rat brain cortical membranes after 15 mins by competition assay,Confirmatory,23792350.0,
1086,763650,2,3,,103165719,5202,Unspecified,112808.0,29595.0,,IC50,Displacement of [3H]-ketanserin from 5HT2A receptor high affinity component in rat brain cortical membranes after 15 mins by competition assay,Confirmatory,23792350.0,
1087,776868,2,3,,103165719,5202,Active,231454.0,3350.0,0.0095,Ki,Displacement of [3H]-8-OH-DPAT from human recombinant 5-HT1A receptor expressed in HEK293-EBNA cells after 120 mins,Confirmatory,24161678.0,
1088,1063806,4,2,,103165719,5202,Active,112822.0,3354.0,0.01072,Ki,Displacement of [3H]5HT from 5-HT1E receptor (unknown origin),Confirmatory,24365159.0,
1089,1076853,2,3,,103165719,5202,Active,1168220.0,3357.0,0.01349,Ki,Displacement of [3H]LSD from 5-HT2B receptor (unknown origin),Confirmatory,24582985.0,
1090,1085232,1,4,,103165719,5202,Unspecified,126716.0,,,,Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated at 300 uM for 10 min before substrate addition and measured after 10 min by spectrophotometry,Other,,
1091,1085233,2,3,,103165719,5202,Unspecified,126716.0,,300.0,IC50,Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 10 min before substrate addition and measured after 10 min by spectrophotometry,Confirmatory,,
1092,1093427,2,3,,103165719,5202,Active,1703010.0,3362.0,0.07,Ki,Binding affinity to Homo sapiens (human) 5-HT6 receptor,Confirmatory,,
1093,1094304,2,3,,103165719,5202,Inconclusive,112808.0,29595.0,,Ki,Displacement of [3H]Ketanserin from 5HT2A receptor in Rattus norvegicus (rat) cerebral cortex by filter binding assay,Confirmatory,,
1094,1094305,2,3,,103165719,5202,Active,112812.0,24473.0,0.009000000000000001,Ki,Displacement of [3H]8-OH-DPAT from 5HT1A receptor in Rattus norvegicus (rat) cerebral cortex after 15 min by filter binding assay,Confirmatory,,
1095,1094306,2,3,,103165719,5202,Inconclusive,114754.0,24925.0,,Ki,Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting,Confirmatory,,
1096,1132780,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.005 ug/ml,Other,671450.0,
1097,1132781,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.00075 ug/ml,Other,671450.0,
1098,1132782,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.001 ug/ml,Other,671450.0,
1099,1132783,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.00050 ug/ml,Other,671450.0,
1100,1132784,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.01 ug/ml,Other,671450.0,
1101,1132785,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.05 ug/ml,Other,671450.0,
1102,1132786,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.1 ug/ml,Other,671450.0,
1103,1132787,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction,Other,671450.0,
1104,1132793,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.00050 ug/ml relative to methacholine,Other,671450.0,
1105,1132794,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.00075 ug/ml relative to methacholine,Other,671450.0,
1106,1132795,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.001 ug/ml relative to methacholine,Other,671450.0,
1107,1132796,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.005 ug/ml relative to methacholine,Other,671450.0,
1108,1132797,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.01 ug/ml relative to methacholine,Other,671450.0,
1109,1132798,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.05 ug/ml relative to methacholine,Other,671450.0,
1110,1132799,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.1 ug/ml relative to methacholine,Other,671450.0,
1111,1132805,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.01 ug/ml in presence of hydroxindasol,Other,671450.0,
1112,1132807,1,2,,103165719,5202,Unspecified,,,,,Peripheral serotoninmimetic activity in Charles River rat uterus assessed as uterine contraction measured as tension developed at 0.01 ug/ml in presence of methylsergide,Other,671450.0,
1113,1141726,1,3,,103165719,5202,Active,8488960.0,3363.0,0.0014,Ki,Displacement of [3H]5-HT from human 5-HT7 receptor expressed in HEK293 cells after 30 mins by microbeta counting analysis,Confirmatory,24763360.0,
1114,1144412,1,1,,103165719,5202,Unspecified,,,,,Fibrinolytic activity in ip dosed rat assessed as blood clot lysis for 4 hrs,Other,1249799.0,
1115,1152680,1,3,,103165719,5202,Active,1703010.0,3362.0,0.033,Ki,Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in CHO cells,Confirmatory,24805037.0,
1116,1152681,1,3,,103165719,5202,Active,8488960.0,3363.0,0.0008,Ki,Displacement of [3H]LSD from human recombinant 5-HT7 receptor expressed in CHO cells,Confirmatory,24805037.0,
1117,1159524,1,1,,124880365,5202,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1118,1159524,1,1,,124880366,5202,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1119,1159580,2,1,,268736334,5202,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1120,1159580,2,1,,273002842,5202,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1121,1159607,2,1,,312596611,5202,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1122,1168801,2,1,,103165719,5202,Active,231454.0,3350.0,0.003,EC50,Agonist activity at 5HT1A receptor (unknown origin) after 20 mins by [35S]GTP-gammaS binding assay,Confirmatory,25308766.0,
1123,1186027,1,2,,103165719,5202,Active,8488960.0,3363.0,0.017,EC50,Agonist activity at human 5-HT7 expressed in HEK-293 cells assessed as increase in cAMP level after 45 mins by HTRF assay,Confirmatory,25073094.0,
1124,1188130,1,2,,103165719,5202,Active,8488960.0,3363.0,,Ki,Displacement of [3H]5-HT from human 5HT7 receptor transfected in CFO-K1 cells after 30 mins by liquid scintillation spectrometry,Confirmatory,25128671.0,
1125,1188131,1,2,,103165719,5202,Active,231454.0,3350.0,0.0020800000000000003,Ki,Displacement of [3H]8-OH-DPAT from human 5-HT1A receptor transfected in CFO-K1 cells after 30 mins by liquid scintillation spectrometry,Confirmatory,25128671.0,
1126,1196313,1,2,,103165719,5202,Active,1703010.0,3362.0,0.033,Ki,Displacement of [3H]LSD from human recombinant 5-HT6 receptor expressed in HEK-293 cells incubated for 60 mins by scintillation counting method,Confirmatory,25557493.0,
1127,1196327,1,2,,103165719,5202,Active,8488960.0,3363.0,0.0008,Ki,Displacement of [3H]LSD from human 5-HT7 receptor expressed in CHO cells,Confirmatory,25557493.0,
1128,1199729,1,2,,103165719,5202,Active,112816.0,3358.0,0.00021,EC50,Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay,Confirmatory,25633969.0,
1129,1199730,1,2,,103165719,5202,Unspecified,112816.0,3358.0,,,Agonist activity at human 5-HT2C receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay relative to 5-HT,Other,25633969.0,
1130,1199732,1,2,,103165719,5202,Active,1168220.0,3357.0,0.0009199999999999999,EC50,Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay,Confirmatory,25633969.0,
1131,1199733,1,2,,103165719,5202,Unspecified,1168220.0,3357.0,,,Agonist activity at human 5-HT2B receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay relative to 5-HT,Other,25633969.0,
1132,1199735,1,2,,103165719,5202,Active,543727.0,3356.0,0.0018800000000000002,EC50,Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay,Confirmatory,25633969.0,
1133,1199736,1,2,,103165719,5202,Unspecified,543727.0,3356.0,,,Agonist activity at human 5-HT2A receptor expressed in HEK293 cells assessed as calcium flux by FLIPR assay relative to 5-HT,Other,25633969.0,
1134,1224859,2,1,,90341122,5202,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1135,1232237,1,1,,103165719,5202,Active,543727.0,3356.0,0.302,EC50,Partial agonist activity at human 5-HT2A receptor expressed in HEK293 cells preincubated for 1 hr at 37 degC followed by incubated for 15 mins at room temperature by IP-One assay,Confirmatory,25583099.0,
1136,1232238,1,1,,103165719,5202,Active,112816.0,3358.0,0.19055,EC50,Partial agonist activity at human 5-HT2C receptor expressed in HEK293 cells preincubated for 1 hr at 37 degC followed by incubated for 15 mins at room temperature by IP-One assay,Confirmatory,25583099.0,
1137,1232239,1,1,,103165719,5202,Unspecified,,,,,Selectivity for human 5-HT2A receptor over human 5-HT2C receptor by IP-One assay,Other,25583099.0,
1138,1234835,1,1,,103165719,5202,Active,231454.0,3350.0,0.02754,EC50,Agonist activity at human 5-HT1A receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation after 15 mins by ELISA,Confirmatory,26081758.0,
1139,1234837,1,1,,103165719,5202,Active,231454.0,3350.0,0.16982,EC50,Agonist activity at human 5-HT1A receptor expressed in CHO cells after 90 mins by beta-arrestin-2 recruitment assay,Confirmatory,26081758.0,
1140,1234840,1,1,,103165719,5202,Unspecified,231454.0,3350.0,,,Agonist activity at human 5-HT1A receptor expressed in CHO cells assessed as ERK1/2 phosphorylation at 1 uM after 5 mins by Western blot analysis relative to control,Other,26081758.0,
1141,1259416,1,2,,340080562,5202,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1142,1259419,1,1,,135651413,5202,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,2233697.0,
1143,1259419,1,1,,135651413,5202,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,8114677.0,
1144,1259419,1,1,,135651413,5202,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,8534270.0,
1145,1259419,1,1,,135651413,5202,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,8663249.0,
1146,1259419,1,1,,135651413,5202,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,12954071.0,
1147,1259419,1,1,,135651413,5202,Active,260099679.0,3356.0,,,Human 5-HT2A receptor (5-Hydroxytryptamine receptors),Other,15322733.0,
1148,1259421,1,1,,340080562,5202,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1149,1259423,1,2,,354780188,5202,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1150,1259423,1,2,,354974867,5202,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
